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Polyether compounds are a subgroup of natural products with regular occurrence 
of multiple C-O-C motifs. The biosynthetic origin of polycylic polethers has been studied 
and the majority of them are derived from polyketide or terpene pathways. Normally, the 
polycyclic polyethers can be divided into two groups based on their structural features: 
the first group features multiple rings that are interconnected by carbon-carbon single 
bond, which are produced by a biosynthetic cascade of exo epoxide-opening reactions; 
the other group has multiple fused cyclic ethers and are formed by an cascade of endo 
epoxide-opening reactions. 
Karenia brevis (K. brevis) is known as principle harmful bloom (HAB) organism 
of the Gulf of Mexico which can cause red tides. Brevetoxins (PbTx) are a suit of cyclic 
polyether ladder compounds produced by K. brevis. Brevetoxins are neurotoxins that can 
bind to voltage-gated sodium channels in nerve and muscle cells, resulting in disruption 
of normal neurological processes causing the human illness which is clinically described 
as neurotoxic shellfish poisoning (NSP). 
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Inspired by Cane-Celmer-Wesley’s proposal regarding monensin biosynthesis, 
Nakanishi and Shimizu proposed a biosynthetic pathway for brevetoxin which suggests 
that PKS-mediated synthesis of the polyene is followed by epoxidation to afford a 
polyepoxide which then undergoes an epoxide-opening cascade, catalyzed by an epoxide 
hydrolase (EH).  
To find evidence to support the hypothesis that an epoxide hydrolase from 
polyether ladder producing dinoflagellates will catalyze the construction of the polyether 
ladder framework from polyepoxide substrates, and to study the role of epoxide 
hydrolase in the biosynthesis of polyether ladder compounds, it is necessary to identify 
and produce one or more epoxide hydrolase from dinoflagellates. The methods to detect 
epoxide hydrolase activity in K. brevis and different techniques to obtain epoxide 
hydrolases from K. brevis are discussed. A microsomal EH identified from a K. brevis 
EST library was cloned and expressed. The characterization of this EH, including 
substrate selectivity and enantioselectivity as well as its potential to catalyze the critical 
ento-tet cyclization epoxy alcohol, is discussed.  
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1. BACKGROUND 
1.1 DINOFLAGELLATE 
Dinoflagellates are members of the class Dinophyceae, which is a diverse group of 
unicellular, flagellate algae that fossil records suggested have been in existence for at 
least 400 million years 1. Dinoflagellates are one of the three main phyla of the protozoan 
taxon Alveolata. The other two are the parasitic apicomplexans and the mostly free-living 
ciliates. Motile dinoflagellate cells have two flagella, one longitudinal and one transverse 
which encircles the cell, and this design causes a corkscrew-like swimming motion from 
which the name dinoflagellate is derived (Greek dinos = whirling). Their unique 
propulsion system has been studied over the last several decades 2. In terms of number of 
species, dinoflagellates are one of the largest groups of marine eukaryotes 3. However, 
the dinoflagellate nuclei are not characteristically eukaryotic, as they lack histones, 
nucleosomes and maintain continually condensed chromosomes during mitosis. However, 
they do contain typically eukaryotic organelles, such as mitochondria, chloroplasts, and 
Golgi bodies 4. Figure 1 shows one dinoflagellate Gonyaulax sp. 
(http://www.sms.si.edu/irlspec/Phyl_Dinofl.htm). 
 
Figure 1. Dinoflagellate Gonyaulax sp. 
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Most dinoflagellates are marine plankton, but more than 200 species are found in 
fresh water 5. Their growth is affected by temperature, salinity or depth. Although many 
dinoflagellates are photosynthetic, a large fraction of these are in fact mixotrophic, 
combining photosynthesis with ingestion of prey 6. Some species are endosymbionts of 
marine animals and play an important role in the biology of coral reefs, for instance 
Symbiodinium, the coral symbiont 7. Other dinoflagellates are predators on other 
protozoa, and some forms are parasitic. They are also known to produce novel secondary 
metabolites including heterocycles, macrolides, highly oxygenated alkyl compounds 
among others 8. The chloroplasts of photosynthetic dinoflagellates have been studied for 
the evolution of organelle genomes. The most common type of dinoflagellate chloroplast 
is bound by 3-membranes and contain chlorophylls a and c2, the carotenoid beta-carotene 
and xanthophylls that seems to be unique to dinoflagellates, mainly peridinin, 
dinoxanthin and diadinoxanthin. Many dinoflagellates show goldenbrown color because 
of these pigments. However, Karenia brevis, Karenia mikimotoi and Karlodinium 
micrum, have other pigments through endosymbiosis, including fucoxanthin 9. Most 
dinoflagellates have a haplontic life cycle. The reproduction type is binary fission, either 
desmoschisis or eleuteroschisis 10. In a small percentage of dinoflagellates, sexual 
reproduction also occurs 11.  
Dinoflagellates can bloom in a very high concentration resulting in red tides. The 
toxins, known as dinotoxins produced by dinoflagellates can kill fish and accumulate in 
filter feeders such as shellfish, which may be passed on to people who eat them. 
However, some dinoflagellate blooms are not hazardous. Bioluminescent dinoflagellate 
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can emit short flashes of light when disturbed. There are more than 28 dinoflagellates 
which are bioluminescent and most of them emit a blue-green light 12. These species 
contain dinoflagellate luciferase, the main enzyme in dinoflagellate bioluminescence and 
luciferin, a chlorophyll derived tetrapyrrole ring which acts as the substrate in the 
luminescent reaction 13.  
The large amount of DNA of dinoflagellate is one of their most striking features. 
Dinoflagellate DNA can range from 3 ~ 250 pg/cell, whereas most other eukaryotic algae 
contain on average 0.54 pg/cell 14. In addition, dinoflagellate nuclei are unique in their 
morphology, composition and regulation.  
 
1.2 KARENIA BREVIS (K. BREVIS) 
Karenia, formerly included in the genus Gymnodinium, is a genus of 12 species of 
dinoflagellates 15. Several species can cause red tides, including K. brevis, and Karenia 
mikimotoi, which was first described in Japan, but is now found in the Atlantic ocean 16. 
These species are similar in their pigmentation and possession of a linear apical groove, 
but can be distinguished by morphological characteristics and large subunit (LSU) rRNA 
gene sequences 17.  
Karenia brevis (genus Karenia species brevis, formerly known as Gymnodinium 
breve and Ptychodiscus brevis) is an unarmored, photosynthetic marine dinoflagellate. It 
is a microscopic, single-celled organism that is responsible for frequent blooms along 
Florida and Texas coastal waters. K. brevis uses its two flagella to move through the 
water in a spinning motion. Karenia brevis cell is about 20-40 μm in size, the cell color is 
yellow-green because of the presence of chloroplasts 18. Karenia brevis has a 1011 bp 
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genome, which is approximately 30 times the human genome. It has permanently 
condensed chromatin lacking nucleosomes. The condensed chromosomes have a 
characteristic banding pattern with stacked disks which form a continuous left-handed 
twist along the longitudinal axis. Due to its huge size, the genome has not yet been 
sequenced 19. Karenia brevis was shown in Figure 2 
(https://upload.wikimedia.org/wikipedia/commons/a/a0/Karenia_brevis.jpg). 
 
Figure 2. Karenia brevis 
 
Karenia brevis can be found in the Gulf of Mexico, along the coasts of Texas, 
Louisiana, Florida, and North Carolina. It is photosynthetic and performs much of the 
area's primary production, which is the synthesis of organic compounds from 
atmospheric or aqueous carbon dioxide 18. Normally, K. brevis moves towards greater 
light 20 and against gravity 21, which results in keeping the cells at the surface of water. 
Because of dependence on light, they cannot live at a depth below 200 feet. The optimal 
temperature for their growth is between 22-28°C, although they can survive in a 
temperature range between 4 and 33 °C. In addition, K. brevis requires salinity between 
25-45 ppt. They can provide oxygen to the environment contributing around 20 % of the 
primary production in the West Florida Shelf during blooms or red tides 22.  
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Multiple reasons may lead to a chemical change in water. The most common is 
when chemicals are dumped into the water from local run-off zones. These chemicals can 
come from certain fertilizers which are used to promote agricultural growth. The algae 
will reproduce rapidly if nutrient levels such as nitrogen increase beyond normal levels, 
resulting in an algal bloom. These blooms can deplete oxygen in the water and create a 
shade from the sun, inhibiting the growth of other autotrophs 23. Karenia brevis can 
produce harmful algal blooms (HABs) or red tides, during which toxins are released in 
the ocean and may kill marine animals, and cause human illness that can arise from 
eating seafood that have retained toxins. Blooms of K. brevis may also provide a 
significant source of fixed carbon thorough photosynthesis 24. With nutrient regimes and 
light conditions, K. brevis can bloom from 100,000 to 250,000 cells/liter within 2 months 
25. Monospecific blooms can cover a surface area of up to 1.4-3.0 × 104 km2 24. An 
historical assessment of K. brevis in the western Gulf of Mexico found documented 
reports of massive fish kills together with human respiratory irritation and dry cough 
from Veracruz, Mexico in the late 1800s, and earlier evidence of red tides on the 
Mexican coastline dating back to the 1500s 26. Throughout most of the Gulf of Mexico 
and US south Atlantic Bight, K. brevis is found in background concentration levels of 1-
1000 cells/liter 25. Blooms are most frequent along the west coast of Florida, especially 
from Clearwater to Sanibel Island. Most commonly, blooms can last more than two 
months in regions of the Gulf of Mexico including: the west Florida shelf, the Campeche 
Bay between Rio Ciatzacoalcos and Rio Grijalva, and the Texas coast between Port 
Arthur and Galveston Bay 25.  
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Karenia brevis has attracted great interest among scientists. Microscopy or 
pigment analysis are among the traditional methods for the detection of K. brevis. 
However, those methods are time-consuming and require an experienced microscopist for 
identification 27. Molecular and PCR based methods for detection of K. brevis cells have 
been developed 28. Another technique, which uses a model-based examination of UV-vis 
spectra, multiwavelength spectroscopy has also been used for detection of K. brevis 29.   
 
1.3 BREVETOXINS 
Brevetoxins (PbTx) are a suit of cyclic polyether ladder compounds. Brevetoxins 
are neurotoxins that can bind to voltage-gated sodium channels in nerve and muscle cells, 
resulting in disruption of normal neurological processes causing the human illness which 
is clinically described as neurotoxic shellfish poisoning (NSP) 30. Brevetoxins have two 
main skeletal types, brevetoxin A and brevetoxin B, which differ in the carbon backbone. 
Each type of brevetoxin has several subtypes, which differ in the side-chain substituents 
31.  
 
Figure 3. Different types of brevetoxins 
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Brevetoxins are lipid soluble and adversely affect human health as well as 
ecosystems. Brevetoxins are most studied in K. brevis, but they are also found in other 
species of Karenia 30. The toxins activate voltage-gated sodium channels in vertebrates 
directly damaging the nervous system of an organism even at very small concentrations. 
This results in neurological symptoms in the affected organism, including humans. The 
most common way for humans to be exposed to these toxins is through the consumption 
of contaminated shellfish. Ecological health effects include massive mortality of 
invertebrates, fish, birds, and some marine mammals. This could be due to either direct 
exposure to the toxins or from the brevetoxins in the food web 32. Due to its extensive 
adverse impacts on coastal environments and communities, the growth physiology and 
toxicity of K. brevis have been studied for over 60 years. Research on the underlying 
molecular biology has not been initiated until the last decade, which is enabled by the 
availability of rapidly evolving molecular technologies from the biomedical field 19. The 
processes contributing to the development of K. brevis blooms span spatial and temporal 
scales from the molecular mechanisms within the cell that respond the environmental 
cues to the oceanographic and even atmospheric processes that drive the local 
environmental conditions in which K. brevis lives. How a bloom is initiated and 
terminated remains poorly understood, but is crucial for the prediction and management 
of bloom impacts. However, the integration of the cellular responses with these physical 
forcings is needed to refine these models. A lack of information on these processes 
severely limits predictive models as they require a more thorough understanding of the 
cellular level decisions through which K. brevis interacts with its environment 19.  
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1.4 POLYETHER COMPOUNDS 
Polyether compounds are a subgroup of natural products with regular occurrence 
of multiple C-O-C motifs. Polyethers are commonly divided into two categories, linear 
and polycylic. The latter group is especially interesting because of the structural diversity 
and biological activities, which include antibiotic, antifungal, and anticancer. The origin 
of polycylic polethers has been studied and the majority of them are derived from 
polyketide, such as brevetoxins (Figure 3, above), or terpene pathways such as ent-
Abudinol B 33 and terurilene 34. Normally, the polycyclic polyethers can be divided into 
two groups based on their structural features: the first group features multiple rings that 
are interconnected by carbon-carbon single bond, and it’s produced by an biosynthetic 
cascade of exo epoxide-opening reactions; the other group has multiple fused cyclic 
ethers and are formed by an cascade of endo epoxide opening 35.  
 
Figure 4. Terpene derived polyethers (left: terurilene; right: ent-Abudinol B) 
 
1.4.1 Ladder polyethers 
Ladder polyethers are one type of polyether with ladder-like configuration. The 
ladder polyethers contain 4 to 32 five- to nine- member fused rings. The first isolated 
polyether ladder compound is brevetoxin B. Numerous others have been found including 
maitotoxin, the largest nonpolymer isolated from natural source 36. Ladder polyethers are 
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known to be associated with harmful algal blooms, commonly referred to as red tide. Due 
to the uniform structures, ladder polyethers show various biological activities ranging 
from extreme toxicity to beneficial anticancer and antifungal character 37. Many ladder 
polyethers and their analogs were found to have the potential to improve human health. 
For example, brevenal, which is also a secondary metabolite of K. brevis, has the 
potential of treatment of the debilitating lung disorder cystic fibrosis (CF) by effective 
clearance of mucus from the lungs 38. Cystic fibrosis afflicts 30,000 people in the United 
States. It has been demonstrated that brevenal is one million times more effective than 
amiloride in enhancing mucus clearance from lungs. However, the supply of this 
dinoflagellate-derived substance is very limited, which has prevented full exploration of 
its therapeutic value. Figure 5 shows two ladder polyethers: brevenal and yessotoxin. 
 
Figure 5. Ladder polyethers (top: brevenal; bottom: yessotoxin) 
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Normally, there are three ways to obtain the natural products: extraction and 
purification from the producing organism, total synthesis or genetically engineering 
biosynthetic pathways in a heterologous host. The first source for obtaining the PE ladder 
is also not practical due to its low yield. Several milligram of brevetoxins may be 
obtained from several hundred liters of K. brevis culture. The total synthesis of many 
natural products, the other source, is quite challenging and time-consuming. The 
chemical synthesis of the PE ladder motif is still extremely challenging, though total 
syntheses of these complex molecules has been accomplished. In 1995, after 12 years of 
effort, the Nicoloau group completed the first total synthesis of a PE ladder, brevetoxin B 
39. Brevetoxin A was first synthesized in 1998 also by Nicoloau group, in 34 steps 40. 
Another synthesis of brevenal, a relatively simple polyether ladder, was described as 
highly efficient, but still the longest linear sequence required no less than 32 synthetic 
steps 41. These compounds were synthesized several times subsequent to the first 
synthesis 41b, 42. However, due to the structural complexity, all syntheses required over 30 
steps and total yields were less than 5% even when the average yield in each individual 
step reached up to 90%.  
Several biomimetic syntheses of PE ladders via epoxides have been reported. The 
epoxide ring opening can proceed via both favored, but undesired exo-tet cyclization and 
the disfavored, but desired endo-tet cyclization. Therefore, strategies to direct the 
cyclization have been introduced into the syntheses by incorporating directing groups to 
favor the endo-tet cyclization or to disfavor the exo-tet 43. More recently, the Jamison 
group utilized a polyxpoxide cascade to construct more than three rings in only one step; 
water was used to overcome the inherent exo-tet selectivity. But this method needs 
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templating of the substrate with a pyran ring. Furthermore, the reaction is slow, the yields 
are poor, and side products were produced.  
 
Figure 6. a) cyclization modes and directing strategies b) Jamison's polyepoxide cascade 
 
1.4.2 Baldwin’s rules 
As mentioned above, one of the biggest challenges challenging for the synthesis 
of PE ladder compounds through the biomimetic routes is that the endo-tet cyclization is 
disfavored. Baldwin’s rule, first proposed by Jack Baldwin in 1976, provides a set of 
guidelines ranking the relative favorability of ring closure in alicyclic compounds 44.  
Relative rates of ring closure of these types of compounds were discussed. These rules 
are not meant to describe the absolute probability that a reaction will or will not take 
place; rather they are used in a relative sense. A disfavored reaction does not have a rate 
that can compete effectively with the other reaction that is favored. However, the 
disfavored product may still be observed 44. Figure 7 (below) showed a ring closure 
reaction in the top, and favor or disfavor of the ring closure in the bottom.   
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Figure 7. Baldwin'rules (top: ring closure reactions; bottom: dis/favored ring closure) 
 
1.4.3 Polyether ionophores 
Besides ladder polyethers, polyether ionophores are another large group of 
polyethers. They are lipophilic carboxylic acids containing multiple five- and six- 
membered cyclic ethers, either as spiroketals or as linked bicyclic ethers. Nigericin and 
lasalocid are the first members isolated in this family 45. Not until an X-ray structure of 
monesin A was disclosed 46 and cation binding abilities of these molecules were first 
examined 47, did this family of polyethers start drawing great attention. Over one hundred 
members in this family have been isolated and characterized, most of which are produced 
by bacteria of the the genus Streptomyces. Their ability to control coccodiosis, a 
devastating poultry disease, and promote growth of ruminant, inspired numbers of 
scientists to isolate novel ionophore polyethers, make efforts on their total synthesis and 
study their biosynthesis. Polyether ionophores can exhibit numerous biological effects 
including antibiotic, anti-obesity and insecticide activity, by disturbing the delicate 
dynamic equilibrium of cations across the cell membrane 48. Figure 8 shows two 
ionophore polyethers tetronomycin and cationmycin. 
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Figure 8. Ionophore polyethers (left: tetronomycin; right: cationomycin) 
 
1.5 POLYKETIDE BIOSYNTHESIS 
Brevetoxins are members of the polyketide family of natural products. 
Polyketides are mostly produced by bacterial, filamentous fungi, plants and algae. 
Polyketides exhibit high structural diversity and vary widely in pharmacological effects, 
but they share a common biosynthetic origin 49. All polyketides carbon backbone 
construction is catalyzed by polyketide synthase (PKS) through a pathway which is 
highly similar to fatty acid biosynthesis. In the polyketide biosynthetic pathway, small 
units derived from acetate, propionate or butyrate, are condensed into a carbon chain by a 
PKS. PKSs have been identified as type I (non-iterative), type II (iterative), and type III 
(chalcone synthase).  
Type I PKSs are large multifunctional enzymes that are organized into modules, 
each of which directs one cycle of chain extension and condensation. Typically, one PKS 
module should contain the ketosynthase domain (KS) that elongates the chain, the acyl 
carrier protein (ACP) that provides a thiol binding site where intermediates are added, 
and the acyl transferase domain (AT) that transfers units from acyl-CoA precursors to the 
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1.6.1 Biosynthesis of ionophore polyethers 
1.6.1.1 Cane-Celmer-Wesley model (1983) 
The fact that the universal building blocks of the polyether carbon skeleton are 
acetate, propionate and butyrate was well recognized by the early 1980s. Studies on the 
orgins of the oxygens in monensin were then carried by Cane and Wesley. They fed 
Streptomyces cinnamonensis, monensin-producing bacterium, with 18O either in 
carboxylic acid precursors 53 or in molecular oxygen 54. Their studies revealed that that 
not all oxygens are derived from the corresponding subunits like acetate, propionate, and 
butyrate, but also from molecular oxygen. The groups of Cane, Celmer and Wesley then 
proposed a unified stereochemical model of polyether structure and biogenesis in 1983 55. 
According to their model for the biosynthesis of monensin A, an all-E polyene precursor 
is first produced from five acetates, seven propionates and one butyrate in a type I PKS 
manner. Then the polyene is oxidized to the corresponding polyepoxide by oxygen. One 
hydroxyl group attacks the ketone forming a hemiketal, triggering a cascade of epoxide-
opening and ring closure leading to the formation of monensin 55. This model was then 
extended to the biosynthesis of all known polyether ionophores.  
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Figure 12. proposed pathway of biosynthesis of monensin 
 
1.6.1.2 Townsend-Basak model (1991) 
Numerous polyether molecules followed Cane-Celmer-Wesley proposal. 
However, despite significant efforts to do so, the all-E premonensin, the proposed 
precursor of monensin was never found. Townsend and Basak then proposed an alternate 
biosynthetic pathway 56. In this model, instead of an all-E precursor, it was proposed that 
monensin may be produced from an all-Z polyene precursor through several oxidative 
cyclizations involving the action of an iron-containing monooxygenase. This proposal 
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was supported by synthetic studies 57 and the work on model systems related to all-Z 
premonensin by McDonald 58.  
 
Figure 13. Townsend-Basak model 
 
1.6.1.3 Leadlay model (2001) 
Another precursor of monensin was proposed by Leadlay in 2001 59. In his 
proposal, a Z,Z,E-polyene is required en route to monensin 59. The biosynthetic gene 
cluster was sequenced in their group. This is the first polyether gene cluster identified. 
They found that this polyketide gene cluster contains twelve modules, which are 
responsible for the incorporation of twelve acyl units of monensin. From the gene cluster, 
the genes monBI, monBII and monCI were identified 60. The products of both monBI and 
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monBII were thought to act as isomerases, supporting their modification of the Cane-
Celmer-Wesley model. Deletion of monCI may lead to accumulation of all-E 
premonensin polyene 61, indicating that the product of monCI, a single oxidase enzyme, is 
required in the production of polyepoxide. MonCII showed significant sequence and 
structural similarity to the EH. However, latter they found that the active site nucleophile 
in MonCII enzyme is a serine, different from the conserved aspartate residue. They then 
reassigned monCII as a thioesterase responsible for releasing the product in monensin 
biosynthesis. Disruption of monBI and monBII genes, which were latter proved to be 
EHs, resulted in the production of partially cyclized intermediates 62, suggesting the 
epoxide opening and ring closure are catalyzed by the MonB enzymes, rather than by the 
enzyme MonCII as previous thought.  
 
1.6.1.4 Biosynthesis of lasalocid 
More direct evidence of the involvement of an enzyme-catalyzed cascade of 
epoxide-opening reactions in the biosynthesis of polyether was provided by Oikawa in 
their study of lasalocid biosynthesis 63. They analyzed biosynthetic genes of lasalocid, 
reavealing high homology of lsd19 to the putative EH genes monBI and monBII. They 
obtained pure Lsd19 enzyme by cloning and expressing the lsd19 gene in E. coli. A series 
of  enzymatic reactions were carried out by incubating the enzyme and prelasalocid 
diepoxides in vitro 64. The efficient transformation of a proposed substrate 
bisepoxyprelasalocid and its synthesized analogue suggested Lsd19 is indeed an EH. 
Leadlay’s in vivo studies on the production of lasalocid in the producing organism and a 
mutant lacking lsd19 clearly demonstrated that Lsd19 changes the regioselectivity of 
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polyether ring formation. They found when Lsd19 is not present, the formation of the 
second ring proceeds the kinetically favored pathway to form isolasalocid, instead of 
lasalocid 65. Latter studies on Lsd19 revealed it is composed two subunits, Lsd19A 
responsible for furan ring formation, and Lsd19B, taking roles in pyran ring formation, 
which are linked by a short loop and are oriented in a head-to-tail fashion.  
 
Figure 14. Comparison of with or without Lsd19 (left: lasalocid; right: isolasalocid) 
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1.6.2 Biosynthesis of ladder polyethers 
Shortly after the structure of brevetoxin B, the first ladder polyether reported, was 
determined in the 1980’s, efforts to understand the biosynthesis of these complex 
molecules began. Stable isotope incorporation experiments using 13C-labelled acetate 
revealed the polyketide origins of the brevetoxins, yet some anomalies in the labeling 
patterns, were also observed 51b, 66. In the feeding experiment, of the 50 carbons of 
brevetoxin B, 16 carbons showed enrichment from [1-13C] acetate, 30 carbons from [2-
13C] acetate, and 4 carbons from methyl-methionine. The origins of the carbon atoms in 
the brevetoxins have been determined, the remainder of the polyether ladder pathway has 
yet to be revealed. Inspired by the Cane-Celmer-Wesley proposal on monensin 
biosynthesis, Nakanishi and Shimizu proposed a biosynthetic pathway for brevetoxin 
which suggests that PKS-mediated synthesis of the polyene is followed by epoxidation to 
afford a polyepoxide which then undergoes an epoxide-opening cascade, catalyzed by an 
EH, to provide the polyether (Figure 15) 51. They believed that the structural and 
stereochemical similarity among brevetoxins are a direct consequence of their 
biosynthetic origin. A single oxidase could be sufficient, as all alkenes in the hypothetical 
polyene precursor would require identical stereoselectivity of epoxidation to produce 
wither an all-S, S or all-R, R polyepoxide. As described above, according to Baldwin’s 
rules 44, 62, epoxide ring opening reactions favors THF rather than THP, suggesting that 
the cascades should have to overcome ten separate disfavored epoxide opening reactions.  
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Figure 15. Proposed biosynthetic pathway of brevetoxin 
 
Although the origins of the carbon atoms in the brevetoxins are confirmed, the 
subsequent epoxidation and cyclizations are still unrevealed. Labeling experiments with 
18O2 revealed that the oxygens in the fused THP diad of okadaic acid are derived from 
molecular oxygen 67, suggesting that an epoxide intermediate is involved in the formation 
of this ladder polyether like motif, which provided support for the proposal.  
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Figure 16. Structure of Okadaic acid 
 
Giner and Mullins proposed that the ladder polyethers are derived from all-Z 
polyene precursor 68. In their proposal, an epoxy ester intermediate undergos cyclization 
with the carbonyl as nucleophile, resulting in the formation of an orthoester. Upon the 
collapse of orthoester, the hydroxyl group attacks the previous electrophilic site of the 
starting cis epoxide, produces the ring in the ladder and generates an ester for next 
cyclization reaction. However, this proposal has not been tested.  
 
Figure 17. Biosynthesis of ladder polyethers in epoxy ester pathway 
 
Recent identification of molecular oxygen (O2) as the source of the ether oxygen 
atoms in the structurally similar PE ladder yessotoxin, produced by the dinoflagellate 
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Protoceratium reticulatum 52 provides significant support for Nakanishi’s proposal. This 
study examined the results of feeding experiment using 18O with either molecular oxygen 
or [18O2] acetate. The analysis of these experiments revealed that the ether oxygens are 
derived from 18O2, and the hydroxyl oxygen is from [18O2] acetate. These results suggest 
that a polyene precursor is oxidized by a monooxygenase after acetate condensation, 
which supports Cane-Celmer-Wesley model, as well as Nakanishi and Shimizu’s 
hypothesis. In addition, it was suggested the direction of epoxide ring formation was 
from tail to head (right to left) and a monooxygenase formed predominantly an all (S, S)-
polyepoxide intermediate from an E-polyene intermediate.  
 
Figure 18. Origins of oxygen in yessotoxin 
 
1.7 EPOXIDE HYDROLASE (EH, E.C.3.3.2.3) 
Epoxide-containing compounds are very widely found in the environment, and a 
large variety of aromatic and alkenic compounds are also metabolized to epoxides 
endogenously 69. An epoxide (also known as oxirane), a three-membered cyclic ether, has 
specific reactivity patterns owing to the highly polarized oxygen-carbon bonds in 
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addition to a highly strained ring 70. Most epoxides are moderately reactive, relatively 
stable at physiological pH, and do not present acute dangers to cells, but they still need to 
be transformed in a controlled manner. EHs can catalyze epoxide hydrolysis to yield the 
corresponding 1,2-diol, which is only one of several ways that cells transform epoxides 71.  
 
1.7.1 Function of EHs 
In different organisms, the role of EHs differs greatly. Generally, EHs have three 
functions: detoxification, catabolism, and regulation of signal molecules. In 
microorganisms, EHs are important in the catabolism of specific carbon sources from 
natural sources, like tartaric acid or limonene 72. However, studies on microbial EHs are 
mainly for their potential use as chiral catalysts for enzymatic syntheses 73. In plants, EHs 
seem important in cuticle formation, responses to stress, and pathogen defense 74. In 
several insects, EHs have also been characterized, where the role of the enzyme is 
mediating developmental chemical, juvenile hormone, and detoxification of many plant 
chemical defenses. In mammals, there are also many EHs, including soluble EH (sEH), 
microsomal EH (mEH), and cholesterol EH (chEH), which hydrolyze the 5,6-oxide of 
cholesterol and other epoxy steroids. In the past 30 years, sEH and mEH have been 
mostly studied. Although these enzymes were first distinguished by their subcellular 
localization, they also have distinct and complementary substrate specificity 75. These 
two enzymes are very concentrated in liver, but they are found in nearly all tissues. They 
are thought to complement each other in detoxifying a wide range of mutagenic, toxic 
and carcinogenic xenobiotic epoxides. However, recent studies found the mEH is 
involved in xenobiotic metabolism and the onset of several diseases 76, and the sEH is 
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involved in the regulation of blood pressure and inflammation 77. What’s interesting is 
that inhibition of the sEH seems to be a potential therapeutic treatment for several 
diseases, including high blood pressure, atherosclerosis, and kidney failure. 
Understanding of EHs mechanism of action is a prerequisite for development of potent 
inhibitors. Although the mechanism has been studied since the enzymes were discovered, 
major breakthroughs were made in the past 20 years because of the availability of 
recombinant EHs 69.  
 
1.7.2 Different types of EHs 
Three types of EH, which operate through distinct catalytic mechanisms, have 
been identified 69. The most studied of these belong to the larger family of hydrolases 
containing an α, β-fold and are often referred to as α, β-hydrolases. All sEH and mEH in 
mammals belong to this category. A second type of EH is the leukotriene-A4 (LTA4) 
hydrolase 78. The LTA4 hydrolase is highly substrate specific, converting LTA4 into 
leukotriene-B4 (LTB4). Only two other substrates, the double bond isomers LTA3 and 
LTA5, have been identified. The third EH is the limonene-1, 2-epoxide hydrolase (LEH), 
which was first identified to hydrolyze limonene 1-2-epoxide to limonene-1,2-diol 
(Figure 19) and recognized as a new type of EH in 1998 79.  
 
Figure 19. LEH hydrolysis 
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1.7.2.1 α, β-fold EH 
Most EHs belong to the α, β-hydrolase fold superfamily of proteins. The α,β-
hydrolase fold is widely found in hydrolytic enzymes of differing phylogenetic origin and 
catalytic function. The core of the enzyme in this family is an α,β-sheet, containing 8 β-
sheets connected by 6 α-helices 80. The enzymes have a catalytic triad, the elements of 
which are borne on loops, which are very conserved structural features of the fold. 
However, the catalytic domains of the enzymes do not share obvious sequence similarity, 
nor do they operate on similar substrates. Nevertheless, they are believed to evolve from 
a common ancestor due to their structural similarity and preservation of the arrangement 
of the catalytic residues 81. Beside EH, this superfamily also includes proteases, lipases, 
peroxidases, esterases, and dehalogenases.  
All known α, β-fold epoxide EHs are characterized by a nucleophile-histidine-
acid catalytic triad. The mechanism is two-step involving the formation of a covalent 
intermediate 82. Before the two-step mechanism was described, the generally accepted 
mechanism was a general-base-catalyzed direct attack of water on the epoxide ring. The 
triad of these enzymes can be described as nucleophile-histidine-acid. Two conserved 
tyrosine residues and a conserved Asp-His-Asp catalytic triad make up the active site. 
The tyrosines are believed to serve as general acids for activation of the epoxide by 
forming two hydrogen bonds with the oxygen 83. The carboxylate group of one of the Asp 
residues is activated by the His and other Asp in the active site and is the nucleophile that 
attacks the epoxide, typically at the least substituted carbon. In a second step a water 
molecule, activated by the His-Asp charge relay, cleaves the ester that is formed, 
liberating the diol and regenerating the enzyme as shown in Figure 20. 
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Figure 20. Mechanism of α, β-fold EH 
 
1.7.2.2 Leukotriene-A4 (LTA4) hydrolase 
Leukotrienes, first discovered in leukocytes, are a class of lipid mediators 
involved in inflammatory and allergic reactions. 5-Lipoxygenase converts arachidonic 
acid into epoxide intermediate LTA4, which is then hydrolyzed into the proinflammatory 
lipid mediator leukotriene B4 (LTB4) by LTA4 hydrolase. LTA4 hydrolase (EC 3.3.2.6) is 
a bifunctional zinc metalloenzyme, besides EH activity, it also exhibits an anion 
dependent aminopeptidase activity. It is commonly believed that peptidase activity is 
involved in the bioactive peptides related to inflammation 78.  
The LTA4 hydrolase is highly substrate specific, converting LTA4 into 
leukotriene-B4 (LTB4). Only two other substrates, the double bond isomers leukotriene A3 
(LTA3) and leukotriene A3 (LTA5), have been identified.  
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Figure 21. Substrates of leukotriene A4 hydrolase 
 
In this enzyme's active site two histidines and a glutamate coordinate a Zn2+ ion, which in 
turn coordinates the epoxide oxygen. Upon activation of the 5, 6-epoxide, an intermediate 
carbocation, whose charge is delocalized over a conjugated triene system, is quenched at 
C-12 by a water molecule which is activated and delivered by a conserved Asp residue, to 
produce a 5, 12-diol rather than a 1, 2-diol. The active site has two domains with 
structures very different from those of α,β-hydrolase. A covalent adduct between the 
enzyme and substrate is not formed in this process making it distinct from the α,β-
hydrolase type. 
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Figure 22. Mechanism of leukotriene A4 hydrolase 
 
1.7.2.3 Limonene EH 
Limonene EH (LEH) was first found to be involved in the limonene degradation 
pathway in Rhodococcus erythropolis, in which it allows the bacterium to grow on 
limonene as carbon source. LEHs do not exhibit any sequence similarity to the α,β-
hydrolases. LEH can hydrolyze limonene-1,2-epoxide to produce limonene-1,2-diol. In 
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both structure and mechanism, LEHs are different from α,β-hydrolase fold EHs. 
Structurally, LEH is much smaller, and does not contain any highly conserved motifs of 
the catalytic triads found in α,β-hydrolase fold EHs and exhibits a novel active site 
structure in the LEH crystal structure 84. LEH contains a curved β-sheet with three α-
helices on top. Five charged residues constitute the active site.  
In LEH, the epoxide is activated by hydrogen bonds to an Asp residue. However, 
as in the case of LTA4 hydrolase, a water molecule is activated and delivered by Asn, Asp 
and Tyr residues in a one-step mechanism and a covalent intermediate is not formed 84. 
Figure 23 shows the mechanism of LEH. 
 
Figure 23. Mechanism of LEH 
 
All EHs which are confirmed to be involved in the biosynthesis of non-ladder 
type polyethers are of the LEH type. Genes coding for LEHs have been identified in the 
biosynthetic gene clusters for the bacterial polyethers monenesin 60, lasalocid 65, 
nanchangmycin 85, tetronomycin 86 and nigericin 87. In the case of monensin 62, 88 and 
lasalocid 63, 89, these EHs encoding genes have been expressed and the EH activity of the 
enzymes confirmed. 
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2. SEARCH FOR EHS 
2.1 INTRODUCTION 
As described previously, EHs are believed to be able to cyclize polyepoxides into 
polyethers 55. EHs from Karenia brevis were proposed to catalyze a kinetically 
disfavored endo-tet cyclization to produce brevetoxins from polyene precursors. There 
are three types of EHs: α,β-fold EHs, limonene EHs, and leukotriene-A4-hydrolase. Most 
known EHs belong to α,β-fold class of EHs.  
 
Objectives 
• Find evidence to support the hypothesis that EH from polyether ladder producing 
dinoflagellates will catalyze the construction of the polyether ladder framework 
from polyepoxide substrates 
• Study the role of EH in the biosynthesis of polyether ladder compounds, and  
• Evaluate the potential of EH in semi-enzyme synthesis.  
 
To achieve these objectives, it is necessary to identify and produce one or more 
EH from dinoflagellates. In this chapter, different methods were described to search for 
various classes of EHs in K. brevis.   
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2.2 RESULTS AND DISCUSSION 
2.2.1 Screening cell free extracts (CFE) 
2.2.1.1 EH detection in Karenia brevis 
Prior to attempting to obtain an EH from K. brevis, it is crucial to prove that 
EH(s) exist in the organism. Detection of EH activity from K. brevis utilized a sensitive 
fluorescent assay as shown below in Figure 24. The substrate 2 was prepared from tran-
styrylacetic acid and 7-methoxy-2-napthaldehyde 90.  
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Figure 24. Synthesis of fluorescent probe 1 
 
Typically, an EH will catalyze epoxide ring opening to yield the corresponding 
1,2-diol. An EH catalyzed hydrolysis of the epoxide substrate, compound 2 produces an 
intermediate diol which lactonizes to release the fluorescent reporter 3 after hydrolysis of 
the intermediate cyanohydrin as shown in Figure 25. 
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Figure 25. EH activity detection strategy 
 
Cell free extracts (CFE) of K. brevis were prepared and evaluated for EH activity. 
The protein concentration of K. brevis CFE was adjusted to 0.25 ~0.5 mg/mL based on 
the Bradford protein assay. Gluocose-6-phosphate dehydrogenase activity was evaluated 
to insure the CFE has retained sufficient enzymatic activity. The concentration of 
fluorescent reporter was calculated for each reading according to a standard curve of the 
reporter.  The result (Figure 26) showed that the K. brevis cell free extracts have 
significant EH activity.  
 
Figure 26. EH activity in K. brevis CFE 
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2.2.1.2 Detection of esterase activity 
Esterase, which hydrolyzes an ester into a carboxylic acid and an alcohol, can also 
catalyze the hydrolysis of the fluorescent probe 2 and produce the fluorescent report 3 
(Figure 27).  
 
Figure 27. Esterase catalyzed hydrolysis yields the same fluorescent reporter as EH 
 
To confirm the activity observed in the K. brevis CFE is due to EH activity not esterase 
activity, the precursor of the fluorescent probe 1 without the epoxide group was used as 
the substrate in the assay. An observation of significant difference (~2 fold in rate of 
formation of fluorescent reporter 3) in EH activity vs esterase activity suggested the K. 
brevis CFE did have EH activity, and that the difference between total activity using the 
EH probe and esterase activity reflected EH activity alone. 
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Figure 28. EH and esterase activity in K. brevis CFE 
 
2.2.1.3 Assays with EH inhibitors 
The EH activity of K. brevis CFE was examined in the presence of known 
inhibitors of two of the three classes of EH: adamantly urea 4, inhibitor of mouse (Ki of 
0.33 μM) and human (Ki of 6.2 μM) α,β-hydrolase type 91 and two inhibitors of the 
Rhodococcus erythropolis LEH: hexylamine 5 (Ki of 35 μM) and valpromide 6 (Ki of 
100 μM) as shown in Figure 29 84. Due to the substrate specificity and unique mechanism 
of the LTA4 hydrolase, it is unlikely that our probe would detect such activity.  
 
Figure 29. Structure of EH inhibitors 
 
The inhibitor of α,β-hydrolase type EH, adamantyl urea 4 was synthesized from 
N-(1-adamantyl) urea 90, as shown in Figure 30 . 
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Figure 31. EH activity in K. brevis cultures and sensitivity to inhibitors (top: EH activity in K. 
brevis CFE in the presence of adamantyl urea; bottom: EH activity in K. brevis CFE in the 
presence of valpromide and hexylamine) 
 
To insure the inhibition observed in the EH assay with adamantyl urea was a result of the 
inhibition of EH rather than esterase, and the sensitivity of the esterase assay to 
adamantly urea was examined using the alkene 1. No inhibition of esterase activity was 
observed under same condition (Figure 32). 
 
Figure 32. Esterase activity in K. brevis cultures and sensitivity to inhibitors 
 
Among the three EH inhibitors, only adamantly urea 4 inhibited the total activity 
in the K. brevis CFE (Figure 31 top) when using the fluorescent probe 2 as the substrate. 
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These data suggested that the observed EH activity in K. brevis CFE can be attributed, at 
least in part, to an EHs of the α,β-hydrolase type.  
 
2.2.2 EH from cDNA library 
After detection of EH activity and inhibition with the known EH inhibitor 
adamantyl urea 4, efforts were made to identify EHs in K. brevis. A K. brevis cDNA 
library served as a resource to search for EHs.  
 
2.2.2.1 Screening from high salt condition 
An EH cDNA was isolated from the plant Solanum commersonii cDNA library by 
plating the cDNA library under high salt conditions (0.8M NaCl) 92. Of the 106 bacterial 
cells plated, only thirteen colonies grew, yielding seven genes related to stress response 
including a soluble EH. The authors speculated that the EH was able to hydrolyze 
reactive epoxides produced during oxidative stress induced oxidative burst. The same 
strategy was used for searching EHs from a K. brevis cDNA library.  
A cDNA library from K. brevis poly (A)+ RNA was constructed in a λ ZAP 
Express vector 93. The phagemid was excised and host cells, E. coli strain, SOLR were 
infected. The cDNA library was plated on high salt plates (2YT agar with 50 ug/mL 
ampicillin, 1mM isopropyl-β-D-thiogalactoside (IPTG) and 0.8 M NaCl). One hundred 
sixty-six colonies (~ 2/3 of what grew) were picked and streaked on the same media. 
Seventy-eight out of 166 grew and were inoculated into LB broth. The plasmids were 
extracted (Qiagen) and sent to Eurofins Genomics for sequencing using T3 primer.  
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tBLASTx analysis was performed for all the sequences returned from Eurofins 
Genomics against the non-redundant protein database of NCBI. Some showed very high 
homology to known genes, such as that of the chloroplast light harvesting protein. 
However, many sequences did not share significant similarity with any known genes. 
Table 1 showed all the sequences with an E value lower than 1e-4 to some known 
sequence. Of forty-six sequence with an E value lower than 1e-4 to NCBI database, eight 
sequences showed homology to complete genome of some organisms, which lead to 
failure to identify the gene. For those assigned sequences, unfortunately, no EH-like 
genes were obtained. The survival strategies in high salt conditions for those recombinant 
cells are not known, but it’s very interesting to find these genes are of high salt stress 
tolerance. 
Table 1. High salt screening results 
Predicated protein 
Accession No. of most similar known 
sequence 
E-value 
Unknown XM_002291564.1 9e-08 
Histone-like protein AF482694.1 6e-24 
Light harvesting protein EF134091.1 3e-88 
Methionine S-adenosyl 
transferase 
AB461927.1 7e-131 
PAP fibrillin family protein XM_002293371.1 9e-30 
RNA binding protein EF134110.1 3e-5 
n-acetylglucosamine-6- XM_001568585.1 3e-38 
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phosphate deacetylase 
Oxidase-like protein XM_002683903.1 9e-22 
Unknown CP001964.1 5e-4 
Carbamoyltransferase family 
protein 
XM_001315691.1 5e-36 
TRP superfamily protein XM_001637522.1 1e-10 
Unknown (basic nuclear protein) EF134106.1 1e-15 
Plectin-like protein XM_002611742.1 3e-14 
Calcium/calmodulin-dependent 
protein kinase 
XM_690776.2 1e-3 
Unknown XM_001737438.1 2e-22 
Amidase CP000828.1 8e-158 
Unknown GU554554.1 9e-12 
Light harvesting protein DQ118623.1 6e-140 
Light harvesting protein DQ118619.1 6e-122 
TPR Domain containing protein XM_001640397.1 2e-127 
Non-transporter ABC protein XM_003080218.1 3e-44 
Phosphoadenosine-
phosphosulphate reductase 
XM_002293751.1 2e-32 
Kenesin XM_002677784.1 4e-23 
Light harvesting protein DQ118623.1 4e-129 
S-adenosylmethionine synthetase DQ865292.1 1e-43 
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Unknown GU554554.1 4e-13 
SET domain-containing protein XM_002952571.1 5e-13 
Chloride channel protein XM_002772754.1 2e-6 
Ribosomal RNA protein DQ779991.1 2e-131 
phosphoglycerate mutase XM_002677423.1 3e-30 
CRE-GRSP-2 protein CP000251.1 2e-6 
Unknown XM_002783593.1 1e-14 
Kinesin-like calmodulin binding 
protein 
XM_002263113.1 8e-37 
WD40-repeat-containing protein CP002013.1 4e-32 
Ubiquitin-like protein EU153190.1 5e-85 
Thioredoxin/protein disulfide 
isomerase 
GU555692.1 5e-29 
Unknown AC140319.3 5e-5 
Hydroxylase XM_002026350.1 5e-7 
Methyltransferase or 
transcriptional regulatory protein 
YP_003265741.1 3e-33 
Adenosylhomocysteinase EU742862.1 1e-29 
Structure specific recognition 
protein 
HP446650.1 1e-10 
Unknown GU554259.1 5e-18 
TPR repeat-containing protein XM_002140365.1 2e-4 
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SGNH-hydrolase superfamily 
protein (lipase or esterase) 
EU449488.1 4e-4 
β-lactamase GQ168544.1 1e-13 
Nitrate transporter protein HM147134.1 3e-35 
 
2.2.2.2 Screening from toxic chemicals 
Another strategy used to screen the K. brevis cDNA library was to grow the E. 
coli in the presence of antibacterial compounds, which can be hydrolyzed by an EH 94. 
The same K. brevis cDNA library described above were plated on a M9 minimal media 
plate containing 0.2% glycidyl butyrate (Figure 33). After incubating overnight, only 12 
colonies grew. The 12 colonies were then streaked on to LB plates to obtain single 
colonies. Plasmids were extracted through mini-prep and were sent to Eurofins Genomics 
for sequencing. After tBLASTx analysis, unfortunately, no EH-related genes were found. 
Table 2 showed all the sequences with an E value lower than 1e-4 to some known 
sequences. Four sequences were found to have an E value lower than 1e-4 to the 
sequences in NCBI database. Only one sequence was able to identify as histone-like 
protein, the other three were unable to assign because they were similar either to a whole 
genome or cDNA of some organisms in NCBI database. 
 
Figure 33. Structure of antibacterial compound, glycidyl butyrate 
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Table 2. Screening using glycidyl butyrate 
Predicated protein 
Accession No. of most 
similar known sequence 
E-value 
Unknown AC103411.8 6e-7 
Unknown GU555355.1 4e-7 
Histone-like protein AF482694.1 4e-31 
Unknown CU367609.1 2e-9 
 
2.2.3 Searching Expressed Sequence Tag (EST) library 
EST is a short sub-sequence of a cDNA sequence. EST libraries are usually used 
to identify gene transcripts. Sequences from a K. brevis EST library consisting of 65,000 
ESTs (22,000 contigs) has been published by The Marine Genomics Project 93. Data 
analysis was made to search for the three types of EHs within this library. 
 
2.2.3.1 Searching for α,β-hydrolase EH 
tBLASTn analysis of the K. brevis EST library against a variety of prokaryotic 
and eukaryotic EHs of the α, β-hydrolase type revealed a transcript (MGID2034061) with 
significant homologies having Expect values ranging from 10-126  to 10-103.  The identified 
EST coded for a 393 amino acid protein with a calculated molecular weight of 44.6 kD. 
BLASTp analysis of this protein against the NCBI non-redundant protein database 
returned a putative EH with Expect value of 10-126, from the polar, eukaryotic microalga 
Coccomyxa subellipsoidea 95 as the closest match. Table 3 shows the alignment of the 
translated protein with the α, β-hydrolase type EH from Aspergillus niger (NCBI 
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Accession Number: CAB 49813.1 96. The two conserved catalytic tyrosine residues can 
be identified in the translated protein. However, the Asp-His-Asp catalytic triad is 
replaced with Asp-His-Glu, which suggests the newly found EH was a microsomal EH 
(mEH) as all known mEHs except the EH from Aspergillus niger have a glutamic acid in 
their catalytic triad 96-97. 
Table 3. Alignment of putative K. brevis EH with Aspergillus niger EH. Catalytic residues are 
highlighted in red. 
K. brevis EH             ----------MPLTDLKPFKLTVPDQQLDDLKYRISATRWPDQLDSPANANWEYGTEITY 50 
Aspergillus niger EH     MSAPFAKFPSSASISPNPFTVSIPDEQLDDLKTLVRLSKIAPPTYESLQADGRFGITSEW 60 
                                     .  . :**.:::**:******  :  :: .    .. :*: .:*    : 
 
K. brevis EH             LKSLAEYWRTTFSWRKQEELLNAMPQFTAKLNGVTVHFVHQRCLSSPTAPALLICHGWPG 110 
Aspergillus niger EH     LTTMREKWLSEFDWRPFEARLNSFPQFTTEIEGLTIHFAALFSERE-DAVPIALLHGWPG 119 
                         *.:: * * : *.**  *  **::****::::*:*:**.   .  .  * .: : ***** 
 
K. brevis EH             SIFEFHKVLGPLAEN-------FHVVAPSIPGYGFSEAP-HKRGFNAPEAARLFHALMLE 162 
Aspergillus niger EH     SFVEFYPILQLFREEYTPETLPFHLVVPSLPGYTFSSGPPLDKDFGLMDNARVVDQLMKD 179 
                         *:.**: :*  : *:       **:*.**:*** **..*  .:.*.  : **:.. ** : 
 
K. brevis EH             LGY-QEYVAQGGDWGSVITQCIGKLFPKQCKAIHINMPTAPRPKD-FDMSKLNPAEVEGL 220 
Aspergillus niger EH     LGFGSGYIIQGGDIGSFVGRLLGVGF-DACKAVHLNLCAMRAPPEGPSIESLSAAEKEGI 238 
                         **: . *: **** **.: : :*  * . ***:*:*: :   * :  .:..*..** **: 
 
K. brevis EH             RRTMAFNTYGTGYQKISGTKPQTLSYGLNDSPIGLLAWMTEKFRDWSDCNGTLENAFTQD 280 
Aspergillus niger EH     ARMEKFMTDGLAYAMEHSTRPSTIGHVLSSSPIALLAWIGEKYLQWVDKP------LPSE 292 
                          *   * * * .*    .*:*.*:.: *..***.****: **: :* *        :..: 
 
K. brevis EH             EILTNAMIYWVSQSIGSSMRFYYENIAVMPGTSKEMIELAAVKVSVPTAVAMFPKEIFFC 340 
Aspergillus niger EH     TILEMVSLYWLTESFPRAIHTYRETTPTASAPNGATMLQKELYIHKPFGFSFFPKDLCPV 352 
                          **  . :**:::*:  ::: * *. .. ....   :    : :  * ..::***::    
 
K. brevis EH             PRAWCEQAYNLQQYTRFEAGGHFAALEKPEELVKDIKDFFLRRLDLDKNQSRL 393 
Aspergillus niger EH     PRSWIATTGNLVFFRDHAEGGHFAALERPRELKTDLTAFVEQVWQK------- 398 
                          **:*   : **  :  .  ********:*.** .*:. *. :  :      
 
 
2.2.3.2 Searching for limonene EH 
tBLASTn 98 analysis of a K. brevis EST library consisting of 22,000 predicted 
transcripts 93 against Rhodococcus erythropolis LEH and nine other known or putative 
LEHs which are associated with biosynthetic gene clusters of bacterial polyethers: 
monenesin (MonB1 and MonB2), lasalocid (Lsd19A and Lsd19B), nanchangmycin 
(NanIA and NanIB), tetronomycin (TmnB), nigericin (NigB1 and NigB3) was 
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performed. All failed to return any significant homologies with the smallest Expect 
values on the order of 10-5. 
Even though data mining of EST library did not give any limonene EH, it still 
cannot exclude the possibility of limonene EH existing in K. brevis. Since many EHs 
have been identified, one possible way to search new EH from K. brevis based on the 
conserved region on the known EHs. The sequences including MonB1, MonB2, Lsd19A, 
Lsd19B, NanIA, NanIB, TmnB, NigB1 and NigB3 can be obtained from NCBI. 
Alignment of these known limonene EHs, revealed two conserved regions, ‘EDPV’ and 
‘GD(E)VD(E)’. Degenerate primers were designed based on these common residue 
sequences 99. No conserved region was found near 3’ end, an oligo dT primer was used as 
K. brevis is eukaryotic, with polyadenylated mature mRNA. 
Table 4. Alignment of some known limonene EH involved in biosynthesis of polyether 
MonBII        -MNEFARKKRALEHSRRINAGDLDAIIDLYAPDAVLEDPVGLPPVTGHDALRAHYEPLLA 59 
NigB1         MIDERSRKKLILEHSRRMNAADVDGLLELYADEVTFEDPVGSGRRTGRDALRAHFEELAA 60 
NanIA         MLNERTRKKIAREHSRRLSEGDIDGLLDLYAKDVTFEAPVGAGGQAGHEALRAHFESAVA 60 
LSD19B        -PDEERRKELAREHCLRINDGDVDGLLKLYSPRIRFEDPVGSWTRTGLEALRAHATMAVG 59 
TmnB          MLDEDARKRVALEYCRRIGAGDVDGVLALFADPLHVEDPVGDKTFTARAEYRAHIARLVS 60 
LSD19A        MPAETVRKEVALEYCRRVNAGELEGVLQLFAPDALLVDPLGTEPVVGRAALAARLAPALR 60 
MonBI         MPDEAARKQMAVDYAERINAGDIEGVLDLFTDDIVFEDPVGRPPMVGKDDLRRHLELAVS 60 
NigBIII       MADEATLKRMALEYARRMNTGDVEAVLDLFSDDIVFEDPVGAPPLIGKDALREHIAWSIE 60 
NanIB         DPDEAALRELPHNYLRLLQKGDVEGTVALFTDDIVFEDPVGGLLLRGKDALREHAFRGSE 60 
                 *   :.   ::   :  .:::. : *::    .  *:*     .      :       
 
Total RNA was isolated from K. brevis. cDNA was obtained by using AMV 
reverse transcriptase (Invitrogen), K. brevis RNA as template and oligo dT as the primer 
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for the first strand cDNA synthesis followed by second strands synthesis using taq DNA 
polymerase. Degenerate primers were designed to amplify EH by PCR using the double 
strandes cDNA as template. PCR conditions were varied through adjusting the annealing 
temperature and Mg2+ concentration. Gradient and touchdown protocols were also 
attempted for PCR. Unfortunately, with different conditions of PCR, products observable 
by gel electrophoresis were obtained infrequently, and all products were much smaller 
than expected size (300 ~500 bp). The products were sent for sequencing and all the 
products turned out to be some unknown sequences without any homology to any other 
sequences. 
Representatives of the limonene type of EH were not identified in either the 
library search or by PCR amplification, which, while unfortunate, is consistent with 
inhibition assays performed on the K. brevis CFE. The involvement of limonene EHs in 
the biosynthesis of bacterial polyethers has been firmly established and it has long been 
believed that the dinoflagellate derived polyether ladders share a common biogenic origin 
with bacterial polyethers including the involvement of one or more EHs. 
 
2.2.2.3 Searching for leukotriene-A4 (LTA4) hydrolase 
tBLASTn analysis against Emeliania huxleii LTA4 hydrolase (NCBI Accession 
number: XP_005787867) returned a single transcript having an Expect value smaller than 
10-5 (3 X10-6). However, BLASTx analysis of the single transcript did not return 
significant homologies to any other LTA4 hydrolase. 
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2.2.3.4 Additional library searches 
Subsequent to these studies, three K. brevis reference transcriptome libraries 
containing 86,580 (Wilson strain), 93,668 (strain SP1) and 84,309 (strain SP3) predicted 
transcripts became available 100. tBLASTn analysis of these transcriptome libraries 
against the 10 LEHs and the Emeliania huxleii LTA4 hydrolase were performed. Against 
the LEHs, a single transcript from the SP1 transcriptome returned an Expect value of less 
than 10-5 (4 X 10-6) against NanIB.  However, BLASTx analysis against the NCBI non-
redundant protein database did not return any significant homologies (10-6 or less). 
Against the Emeliania huxleii LTA4 hydrolase, six transcripts from each library with 
expect values ranging from 10-12 to10-141 were identified. All 18 sequences are BLASTed 
against the database in NCBI, revealing the three transcripts with the lowest E value 
showed very high homology with known LTA4 hydrolase. These three sequences are 
from three libraries respectively and alignment results showed they are identical 
sequences. The remaining sequences were suggested to be aminopeptidase, which is not 
surprising because the query protein LTA4 hydrolase is a bifunctional protein, the second 
function of which is aminopeptidase 101.  
The cDNA sequence of the α,β-EH which was found in Marine Genomics  K. 
brevis EST library was used as a query for a nucleotide BLAST analysis of the three 
reference transcriptomes. Each of theses transcriptome libraries returned identical 
sequences (Locus 28231 from SP1; Locus 35217 from SP3; Locus 51025 from Wilson) 
each having Expect values ranging from 10-79 to10-84. Additionally, a single transcript 
which was identical to the previously found EH was identified in the SP3 library (SP3 
Locus 73930). When the newly identified sequence (Locus 28231 from SP1) was used as 
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a query to search the Marine Genomics EST library, a single 50 bp sequence was 
returned which exactly matched the query. The alignment of these two α,β-EHs is shown 
in Table 5. 
Table 5. Alignment of two K. brevis mEHs. Catalytic residues are highlighted 
K.brevis EH1      -------------------------------------------------MPLTDLKPFKL 11  
K.brevis EH2      MLKIAGGICCILFVAFLSALPIIIDKLFIPTPPRSPEALLRSETEWGNEPEMSDIQPYKI 60 
                                                                     ::*::*:*:   
K.brevis EH1      TVPDQQLDDLKYRISATR-WPDQLDSPANANWEYGTEITYLKSLAEYWRTTFSWRKQEEL 70  
K.brevis EH2      AYDLKHLTDLRRRLLSWRPWSDTVPMAHSKNSSYGVNPKYMQSLISYWRDTYNWRSYEQK 120 
                  :   ::* **: *: : * *.* :  . . * .**.: .*::** .*** *:.**. *:    
K.brevis EH1      LNAMPQFTAKLNGVTVHFVHQRCLSSPTAPALLICHGWPGSIFEFHKVLGPLAEN---FH 127  
K.brevis EH2      INSLGLKSTTIDGLRLVFHEVNGGKQ---KAILLLHGWPGSIHEFSKVLLKINASTQEYS 177 
                  :*::   ::.::*: : * . .  ..    *:*: *******.** ***  :  .   :    
K.brevis EH1      VVAPSIPGYGFSEAPHKRGFNAPEAARLFHALMLELGYQEYVAQGGDWGSVITQCIGKLF 187  
K.brevis EH2      IVCPSLPGFGFSSAPTEEGYSSVEMALTLLRLMAKLKYRTFVVQGGDWGSVVARAMAYID 237 
                  :*.**:**:***.** :.*:.: * *  :  ** :* *: :*.********:::.:. :    
K.brevis EH1      PKQCKAIHINMPTAPRPKD---FDMSKLNPAEVEG--LRRTMAFNTYG----TGYQKISG 238  
K.brevis EH2      PVSVIGLHLNFFPVLPPPGTYVFDMFKVWAFDDENSKSRAKKLLDVNGLFQITGYFHQQA 297 
                  * .  .:*:*: ..  * .   *** *: . : *.   * .  ::. *    *** : ..   
K.brevis EH1      TKPQTLSYGLNDSPIGLLAWMTEKFRDWSDCNGTLENAFTQDEILTNAMIYWVSQSIGSS 298  
K.brevis EH2      TMPETLGFALSDSPAGLAAWILEKFQGWSDPDRPIEDKFRRDDLLTNIMLYWLTNTITSS 357  
                  * *:**.:.*.*** ** **: ***:.*** : .:*: * :*::*** *:**::::* **   
K.brevis EH1      MRFYYENIAVMPGTSKEMIELAAVKVSVPTAVAMFPKEIFFCPRAWCEQAYN-LQQYTRF 357  
K.brevis EH2      MRMYKEVVSLEA------ISVLYLPVTVPVGISLFPHEVLSPPDTVIKKHFTNIVQFTKH 411  
                  **:* * ::: .      *.:  : *:**..:::**:*::  * :  :: :. : *:*:.   
K.brevis EH1      EAGGHFAALEKPEELVKDIKDFFLRRLDLDKNQSRL 393  
K.brevis EH2      KQGGHFAALEEPKAFTDDLLAFLAKLPKSVPGTDTN 447 
                  : ********:*: :..*:  *: :  .   . .   
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2.2.3.5 Analysis of identified EHs 
As described previously, most known EHs are α,β-fold EHs. In mammals, there 
are two types of α,β-fold EHs: soluble (or cytosolic) EH (sEH) and microsomal EH 
(mEH). The mEHs are believed to be involved in the metabolism of xenobiotics whereas 
the sEHs are thought to be involved in the metabolism of fatty acids 69. However, only 
mammalian genomes encode both sEH and mEH whereas yeast, fungi, insects and plants 
encode only one type and the role of the absent EH type may be assumed by the other. 
These two types of EHs were first distinguished by their subcellular localization, but they 
were found to have distinct and complementary substrate specificity. Generally, sEH 
seems to prefer trans-di-, tri- and tetra- substituted epoxides, whereas mEH prefer mono- 
and cis-di- substituted epoxides 75. All the known mEH except that from Aspergillus 
niger have the catalytic triad Asp-His-Glu, whereas most sEH have an Asp-His-Asp 
instead. The mutation of glutamic acid in the rat mEH to aspartic acid increased the 
enzyme activity by more than an order or magnitude 102. Mutation of aspartic acid in the 
Aspergillus niger EH to glutamic acid led to an activity reduction by half 97. The 
mechanisms of these two enzymes are the identical, except difference in the aspartic acid 
and glutamic acid. Both of the two found EHs in K. brevis have glutamic acid rather than 
aspartic acid, suggesting they are mEHs.  
Besides the catalytic triad, a highly variable N-terminal domain is another way to 
distinguish sEH and mEH. Both of the α,β fold type EHs identified in K. brevis belong to 
the mEH class. The N-terminal domains of mEHs are characterized by a microsomal 
domain which may or may not be preceded by an N-terminal membrane anchor. The 
membrane anchor is found in mammalian and insect mEHs, but not in EHs from yeast, 
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fungi or bacteria and is also absent in the two K. brevis mEHs. EHs may be further 
categorized according to the length of two loops: the NC-loop which links the N-terminal 
catalytic domain and the cap domain (the cap domain contains the two catalytic Tyr) and 
the cap-loop, which links two α-helices (α6 and α7) within the cap domain. The length of 
these loops may be determined from the pair wise alignment with the EH from A. niger 
(also an mEH) or by inspection of a homology model constructed using the A. niger EH 
crystal structure as template 103. In A. niger the NC loop is located from Leu215 to 
Leu249 (35 residues) whereas the cap-loop is located from Trp284 to Ser291 (8 residues). 
The lengths of the NC loops of the K. brevis EHs are 36 and 43 residues whereas both 
cap-loops are 14 residues.  mEHs are characterized by having long to very long NC- 
loops (33 or more residues) and short to medium cap-loops (8-36). The K. brevis NC-
loops and cap-loops would be considered very long and medium in length, respectively. 
The length of these domains is believed to govern the substrate selectivity of the EH and 
this combination of long/med NC-loop/cap-loop would suggest selectivity for aromatic 
epoxides.  
 
2.3 MATERIAL AND METHODS 
2.3.1 Material 
Substrate 2 was prepared from trans-styrylacetic acid and 7-methoxy-2-
napthaldehyde, as previously described 90. Chemicals were purchased from Sigma-
Aldrich (St. Louis, MO). K. brevis culture (Wilson strains) were obtained from Mote 
Marine Laboratory (Sarasota, Florida) and maintained in L1-Si medium, with the 
exception that the NH 15 vitamin supplement 104 replaced the L-1 supplement, in a 
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growth chamber at 20ºC. Growth was monitored by counting a 1:10 dilution of culture in 
Z-pak reagent using a Beckman Z-series Coulter Counter with aperture size between 
10~30 μm according to the manufacturer’s instructions. Coomassie Plus Protein Assay 
Reagent for Bradford assay was purchased from Pierce (Grand Island, NY). Absorbance 
and fluorescence were read on a Synergy™ 2, micro-plate reader from Bioteck 
Instrument, Inc (Winooski, VT). Reagents for the glucose-6-phosphate dehydrogenase 
assay were purchased from Sigma-Aldrich. 
 Reagents for RNA isolation were purchased from Sigma-Aldrich. 2YT agar for 
growing recombinant E. coli was purchased from Becton Dickinson (Franklin Lakes, NJ). 
Plasmid extraction kit (QIAprep Spin Miniprep Kit) was purhased from Qiagen 
(Valencia, CA). Sequencing was performed by Eurofins Genomics (Huntsville, AL). 
 
2.3.2 Methods 
Prep of K. brevis cell free extract (CFE) 
K. brevis culture (200 mL) was concentrated by centrifugation (5 min at 450 x g) 
and the supernatant discarded. The cells were resuspended in phosphate buffer (800 μL, 
50 mM pH 7.0) and vortexed for 1 min. This suspension was centrifuged (14,000 x g for 
10 min) and the pellet was discarded. Homogenates were analyzed for protein 
concentration and glucose-6-phosphate dehydrogenase activity as described below. 
Typical protein concentrations ranged from (0.25 to 0.5 mg/mL).  
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activity of homogenate is more than twice that of boiled homogenate. Each sample was 
assayed in triplicate.  
 
Figure 35. A typical G6PD assay 
EH/esterase assay 
Fluorescent probe 1/2 (2 μL, 10 mM in DMSO, final concentration100 μM) was 
added to K. brevis CFE (198 μL) in duplicate. Fluorescence was monitored at 330 nm 
EX/ 465 nm EM (Synergy™ 2, Bioteck Instrument, Inc.) every 5 minutes at 30°C. For 
each data point, n = 2; the range is within the data point. The concentration of reporter 3 
was calculated from a calibration curve prepared by measuring the fluorescence of 7-
methoxy-2-naphthaldehyde (reporter 3) (0, 3.1, 12, 25, 50 μM in phosphate buffer (50 
mM phosphate, pH 7.0). Each reporter 3 solution was assayed in duplicate; error bars are 
smaller than data points. 
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washed with cold 70% EtOH (700 µL). After air-drying, the pellet was reconstituted in 
water (50 µL).  Total RNA concentration was quantitated using the Nanodrop 2000 
(Thermo Scientific) 
 
PCR reactions 
 Degenerate primers were designed based on the conserved region mentioned 
previously. Two forward primers (GTATATTGYNCARGGNGGNGAYTGG) and 
(TACCNWSNHTNCCNGGNTAYGGNT)  were paired with oligo dT primer 
respectively. The PCR reaction components were mixed according to the Taq DNA 
polymerase manufacurer’s instructions. The concentration of each component in PCR are 
as following: dNTP (200 µM), reaction buffer (1x), primers (0.05-1 µM for both forward 
and reverse), template cDNA (< 1,000 ng), Taq DNA polymerase (1.25 unit/50 µL PCR). 
Typical reactions were carried out by using the following steps: initial denaturation at 94 
ºC for 2 minutes followed by 35 cycles of 94 ºC for 15 seconds (denaturation), 65 ºC for 
30 seconds (annealing), and 68 ºC for 30 seconds (extension). Gradient annealing 
temperatures (65, 63, 61, 59, 57, 55, 53, 51 ºC) were used to find optimize condition. A 
touchdown reaction with annealing temperature decrease from 65 to 51 ºC in first eight 
cycles was also tested.  
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3. CLONING, EXPRESSION AND ANALYSIS OF EH 
3.1 INTRODUCTION 
As described in the previous chapter, one EH was found from the Marine 
Genomics Project K. brevis EST library. It could be heterologously expressed in bacteria. 
To find evidence to support the hypothesis that EH from polyether ladder producing 
dinoflagellates will catalyze the construction of polyether ladder framework from 
polyepoxide substrates, it is necessary to carry out a series of in vivo enzymatic reactions. 
Similar behavior on proposed natural substrates and on designed substrates would 
strongly support the role of EH in brevetoxin biosynthesis.  
 In this chapter, one EH from K. brevis was cloned, expressed and characterized 
using different substrates. The potential of this EH in semi-enzyme synthesis of cyclic 
ethers was evaluated using a simple substrate trans-4,5-epoxy-hexanol. The EH activity 
and relative EH mRNA levels were evaluated in two strains of K. brevis in an effort to 
identify a correlation between EH activity or mRNA expression with the brevetoxin 
content.  
 
3.2 RESULTS AND DISCUSSION 
3.2.1 Cloning and expression of K. brevis EH 
As the EH was to be expressed in E. coli, optimization of the codon usage is 
necessary to improve the heterologous expression. The EH sequence found in K. brevis 
EST library was sent to Genescript (Piscataway, NJ) for optimization and synthesis. The 
optimized EH DNA sequence was synthesized and cloned into pUC19 by Genescript. 
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Table 6 shows the native and optimized sequence, the nucleoside without the stars are 
optimized for E. coli codon usage.  
Table 6. Comparison of optimized (for E. coli) and native K. brevis EH sequence 
optimized       ATGCCGCTGACGGATCTGAAACCGTTCAAACTGACCGTTCCGGATCAGCAGCTGGATGAT 60  
native          ATGCCGTTGACTGATTTGAAACCCTTTAAGCTTACTGTGCCTGATCAGCAGCTGGATGAT 60 
                ****** **** *** ******* ** ** ** ** ** ** ******************   
optimized       CTGAAATATCGTATCTCTGCCACCCGCTGGCCGGATCAGCTGGATAGTCCGGCGAACGCC 120  
native          TTAAAGTATCGCATCTCTGCCACACGCTGGCCAGACCAGCTGGATTCACCTGCTAATGCA 120 
                 * ** ***** *********** ******** ** *********   ** ** ** **    
optimized       AATTGGGAATATGGCACCGAAATTACGTACCTGAAAAGCCTGGCAGAATACTGGCGTACC 180  
native          AACTGGGAATATGGGACTGAAATCACTTACTTGAAAAGCTTGGCGGAATACTGGCGCACC 180 
                ** *********** ** ***** ** *** ******** **** *********** ***   
optimized       ACGTTTTCTTGGCGCAAACAGGAAGAACTGCTGAACGCAATGCCGCAGTTCACGGCGAAA 240  
native          ACGTTCAGCTGGCGTAAACAAGAAGAGCTTCTCAATGCAATGCCCCAGTTTACTGCAAAG 240 
                *****    ***** ***** ***** ** ** ** ******** ***** ** ** **    
optimized       CTGAATGGCGTGACCGTTCATTTTGTTCACCAGCGTTGCCTGAGCTCTCCGACCGCACCG 300  
native          CTGAACGGTGTGACAGTGCACTTTGTTCACCAGCGCTGCTTGAGCAGTCCGACAGCACCT 300 
                ***** ** ***** ** ** ************** *** *****  ****** *****    
optimized       GCACTGCTGATTTGTCATGGCTGGCCGGGTAGCATCTTTGAATTCCACAAAGTGCTGGGT 360  
native          GCTCTGCTGATTTGCCATGGCTGGCCAGGCTCTATCTTTGAGTTTCACAAGGTGCTGGGT 360 
                ** *********** *********** **    ******** ** ***** *********   
optimized       CCGCTGGCCGAAAACTTTCATGTGGTTGCACCGAGTATTCCGGGCTATGGTTTTAGCGAA 420  
native          CCTTTGGCTGAGAATTTCCATGTCGTCGCCCCATCTATTCCTGGGTATGGCTTCTCAGAG 420 
                **  **** ** ** ** ***** ** ** **   ****** ** ***** **    **    
optimized       GCGCCGCATAAACGTGGTTTCAATGCACCGGAAGCAGCACGTCTGTTTCACGCACTGATG 480  
native          GCTCCACACAAGCGTGGTTTCAACGCTCCGGAAGCAGCCCGTTTGTTTCATGCACTCATG 480 
                ** ** ** ** *********** ** *********** *** ******* ***** ***   
optimized       CTGGAACTGGGTTATCAGGAATACGTTGCGCAGGGCGGTGATTGGGGCTCTGTGATTACG 540  
native          CTTGAGCTTGGATATCAAGAGTACGTCGCTCAAGGAGGTGATTGGGGGTCGGTGATCACG 540 
                ** ** ** ** ***** ** ***** ** ** ** *********** ** ***** ***   
optimized       CAGTGCATCGGTAAACTGTTTCCGAAACAGTGTAAAGCAATTCACATCAACATGCCGACC 600  
native          CAATGCATAGGCAAGCTGTTTCCAAAGCAGTGCAAAGCCATCCACATCAACATGCCAACG 600 
                ** ***** ** ** ******** ** ***** ***** ** ************** **    
optimized       GCACCGCGTCCGAAAGATTTCGATATGTCTAAACTGAACCCGGCAGAAGTGGAAGGTCTG 660  
native          GCACCACGTCCGAAGGACTTCGACATGTCCAAGCTGAATCCAGCAGAAGTAGAAGGCCTA 660 
                ***** ******** ** ***** ***** ** ***** ** ******** ***** **    
optimized       CGTCGCACGATGGCATTTAATACCTATGGCACGGGTTACCAGAAAATCAGTGGTACCAAA 720  
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native          AGGCGTACAATGGCATTCAATACTTACGGCACTGGGTACCAGAAGATTTCAGGCACCAAA 720 
                 * ** ** ******** ***** ** ***** ** ******** **    ** ******   
optimized       CCGCAGACGCTGAGCTATGGCCTGAATGATTCTCCGATTGGTCTGCTGGCGTGGATGACC 780  
native          CCTCAAACATTATCTTATGGATTGAATGATTCTCCCATTGGGCTATTGGCATGGATGACG 780 
                ** ** **  *    *****  ************* ***** **  **** ********    
optimized       GAAAAATTCCGTGATTGGAGCGATTGCAACGGTACCCTGGAAAATGCGTTTACGCAGGAT 840  
native          GAGAAGTTCCGCGATTGGAGTGATTGCAATGGCACCTTGGAGAATGCATTCACACAAGAC 840 
                ** ** ***** ******** ******** ** *** **** ***** ** ** ** **    
optimized       GAAATTCTGACCAACGCCATGATCTACTGGGTTTCTCAGAGTATTGGCAGTAGCATGCGC 900  
native          GAAATACTCACAAACGCAATGATATATTGGGTCTCTCAGTCAATCGGCTCAAGCATGCGA 900 
                ***** ** ** ***** ***** ** ***** ******   ** ***   ********    
optimized       TTCTATTACGAAAATATCGCCGTGATGCCGGGTACGAGTAAAGAAATGATTGAACTGGCA 960  
native          TTCTACTATGAAAATATTGCAGTGATGCCTGGAACAAGTAAAGAAATGATTGAACTTGCT 960 
                ***** ** ******** ** ******** ** ** ******************** **    
optimized       GCGGTGAAAGTTAGCGTGCCGACCGCCGTTGCAATGTTTCCGAAAGAAATCTTTTTCTGC 1020  
native          GCTGTAAAGGTATCAGTTCCGACAGCCGTTGCGATGTTTCCCAAGGAAATATTTTTCTGT 1020 
                ** ** ** **    ** ***** ******** ******** ** ***** ********    
optimized       CCGCGTGCGTGGTGTGAACAGGCCTATAACCTGCAGCAGTACACCCGCTTTGAAGCGGGC 1080  
native          CCGCGAGCTTGGTGCGAACAAGCCTACAATCTGCAGCAGTATACTAGATTTGAGGCGGGT 1080 
                ***** ** ***** ***** ***** ** *********** **  * ***** *****    
optimized       GGTCATTTCGCCGCACTGGAAAAACCGGAAGAACTGGTGAAAGATATCAAAGATTTCTTT 1140  
native          GGACACTTCGCAGCACTCGAGAAGCCGGAGGAACTTGTGAAGGACATCAAGGATTTCTTC 1140 
                ** ** ***** ***** ** ** ***** ***** ***** ** ***** ********    
optimized       CTGCGTCGCCTGGATCTGGATAAAAATCAGAGCCGTCTGTAA 1182 
native          CTGAGGAGATTGGACTTGGACAAAAATCAAAGCAGGCTCTAG 1182 
                *** *  *  ****  **** ******** *** * ** **  
 
Specific primers (Forward: CACAATCATATGCCGCTGACGGA, Reverse: 
AATAAGCTTTAATGATGATGATGATGATGCAGACGGCTCTGATTTTTAT) were 
designed to amplify the codon optimized K. brevis EH. The primers incorporated HindIII 
(reverse primer) and NdeI (forward primer) restriction sites for directional cloning and 6 
histidine codons (reverse primer). Because NdeI needs at least 6 extra nucleotides at both 
sides of cutting site, the amplified gene was first ligated into a TA vector, pCR2.1 to 
improve digestion efficiency. The recombinant pCR2.1-KbEH was then transformed into 
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E. coli competent cells and extracted using a mini-prep kit (Qiagen). After double 
digestion with HindIII and NdeI, the KbEH gene and expression vector pET30a+ were 
ligated to construct the final recombinant plasmid (Figure 37). 
 
Figure 37. Recombinant pET-30a+-KbEH 
 
The recombinant plasmid pET30a+ was transformed into E. coli strain BL21/DE3 
for protein expression. After induction by IPTG, protein was then extracted and purified 
by nickel affinity chromatography. Molecular mass was confirmed to be 44 kD by SDS 
polyacrylamide gel electrophoresis (PAGE) comparing with protein ladder (Figure 38).  
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3.2.3 EH vs Esterase activity 
The EH found in the Marine Genomics K. brevis EST library is an α, β-fold EH, 
which belongs to α, β-fold hydrolase superfamily. Esterases, the hydrolase enzymes that 
hydrolyze esters into an acid and an alcohol, also belong to this superfamily 81. In the 
method we used to determine EH activity, if the enzyme is an esterase rather than EH, the 
fluorescent report will also be produced, as shown in Figure 27.  
In order to confirm the enzyme obtained is EH rather than esterase, the precursor 
of the fluorescent probe without the epoxide group was used as the substrate in the assay. 
The expressed protein showed no activity with the alkene demonstrating that the enzyme 
was EH. 
 
Figure 40. EH vs esterase activity in K. brevis EH 
 
3.2.4 Optimization of fluorescent substrate 
It was reasoned that a substrate containing aliphatic rather than aromatic 
substituents would be more representative of the native substrate if it were involved in 
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using the sensitive fluorescent assay with different substrate concentration (100 µM, 
75µM, 50µM and 25µM). Other substrates having no fluorescent reporter group were 
evaluated by GC-MS analysis of the reaction mixtures using 1-naphthol as an internal 
standard. A standard curve was obtained by using different substrate/internal standard 
ratio (10:1, 8:1, 6:1, 4:1, 2:1, 1:1, 1:2, 1:4, 1:6, 1:8, 1:10). Figure 43 shows the molar 
ratio vs GC-MS response ratio of styrene oxide and internal standard. 
 
Figure 43. Molar ratio/GC-MS response ratio of styrene oxide 
 
Enantiomers of styrene oxide and 1-butane oxide were used to evaluate the 
enantioselectivity of the enzyme. Figure 44 shows the substrates used in kinetic studies.  
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Figure 44. Epoxide substrates used in kinetic studies. 
 
The data shown in Table 7 indicates that aliphatic substitutents are preferred over 
aromatic substituents by approximately 5:1 and the enzyme shows only a slight 
preference for R over S enantiomers.  
 
Table 7. Kinetic parameters of the K. brevis EH with various substrates 
Substrate KM (μM) kcat (sec-1) kcat (sec-1)/Km (M) 
Probe 2 (R = Ph) 
Probe 2b (R = Et) 
(R) styrene oxide 
(S) styrene oxide 
Racemic styrene oxide 
α-methylstyrene oxide 
(R) 1-butane oxide 
Racemic 1-butane oxide 
1,2,7,8-diepoxyoctane 
13.6 
161 
6240 
6430 
6570 
5310 
25,800 
22,200 
4800 
7.81E-4 
4.46E-3 
9.01E-1 
8.32E-1 
8.58E-1 
3.31E-1 
6.15 
5.36 
7.12 
57.4 
27.7 
144 
129 
131 
62.3 
238 
241 
1480 
 
With the exception of the fluorescent probes 2 and 2b, all the substrates above are 
terminal epoxides. Other substrates with substituentes on both ends of epoxide were 
synthesized from the corresponding alkene by epoxidation with dimethyldioxirane 
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(DMDO) 105 and tested, but the reaction rates were too slow to be determined using the 
GC-MS method. However, disubstituted epoxides proved to be competitive inhibitors of 
the K. brevis EH. Fluorescent probe 2b was used as substrate (100 μM), along with 
different concentrations of these non-terminal epoxides as inhibitors. IC50 data was 
obtained for the aromatic inhibitors. No inhibition was observed when using cis-2,3-
epoxybutane and 2,3-dimethyl-2,3-epoxybutane as inhibitors. Data in table 8 showed cis-
β-methylstyrene oxide has the lowest IC50, which indicated it was the most preferred 
substrate among these substrates. This is consistent with the previous reports that 
microsomal EH prefer cis- over trans- substituted epoxides 75. 
 
Figure 45. Non-terminal epoxides 
 
Table 8. IC50 for non-terminal epoxides using fluorescent probe 2b as substrate 
Substrate IC50 (mM) 
 cis-β-methylstyrene oxide 3.05 
trans-β-methylstyrene oxide 14.28 
β-dimethylstyrene oxide 6.99 
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cis-2,3-epoxybutane                         - 
2,3-dimethyl-2,3-epoxybutane - 
 
3.2.6 Assesment of EH catalysis of a cyclization reaction 
A noteworthy distinction between the monensin pathway and the proposed 
brevetoxin pathway is the site of nucleophilic attack on the epoxide substrate (Figure 45). 
In the case of non-ladder polyethers, the majority of epoxide ring opening reactions 
proceed via attack at the proximal carbon (exo-tet cyclization) while polyether ladder 
formation requires attack at the distal carbon (endo-tet cyclization). Both the empirical 
Baldwin’s rules 44 and molecular orbital calculations indicate that the endo-tet cyclization 
pathway is kinetically disfavored.  The exception among the bacterial polyketides is 
lasalocid. In this polyether, the pyran ring arises from the endo-tet cyclization of an 
intermediate epoxide. This reaction is catalyzed by the EH Lsd19. Lsd19 is a bifunctional 
enzyme consisting of two domains (A and B). Each domain is responsible for the 
cyclization of one of the rings. Lsd19B catalyzes the endo-tet cyclization (Figure 14 in 
chapter 1).  
The ability of the K. brevis EH to perform cyclization was also evaluated. As the 
natural substrate analog of K. brevis are highly challenging to synthesize, the substrate 
trans-4,5-epoxy-hexanol 7 was prepared as previously described 105. This substrate may 
undergo endo-tet cyclization to produce pyran 8, or exo-tet cyclization to produce furan 
9, or simple epoxide hydrolysis to produce the triol 10. The substrate was incubated with 
the expressed EH in reaction buffer and the reaction was monitored by GC-MS.  All three 
possible products were identified by GC-MS 105, by comparison with authentic samples 
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however, neither the percent conversion nor the product ratio differed from that of the 
buffer alone. 
 
Figure 46. Alternate cyclization reactions or hydrolysis 
 
3.2.7 EH activity/expression and toxin content over the life of a culture 
Two cultures of K. brevis whose toxin content differs by ten-fold were evaluated 
over a period of three weeks for EH activity and EH mRNA levels. Both cultures are of 
the Wilson strain. However, toxin production of one culture suddenly dropped for reasons 
which are not yet understood. We are unaware of any studies which have uncovered any 
metabolic differences between these two cultures until now.  
EH activity was assessed using the EH/esterase probe set 1b/2b (ethyl probes).  
Esterase activity, determined using probe 1b, was subtracted from total activity. Cultures 
were diluted on day 0 to equal cell counts (~20,000 per mL) and monitored over a 21 day 
period. As shown in figure 47, 48, EH activity for the high toxin culture was consistently 
higher than that of the low toxin culture. On average, EH activity for the high toxin 
culture was 18% and 60% higher than the low-toxin culture when normalized to protein 
content or to cell counts, respectively. Over the three weeks that the cultures were 
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monitored, both showed a slight drop in EH activity when normalized to protein content 
and an increase in activity when normalized to cell counts.  
 
Figure 47. Left: EH activity of two strains of K. brevis  over a 21 day period; right: average EH 
activity of two strains of K. brevis over 21 day period (normalized to protein concentration) 
 
 
Figure 48. EH activity of two strains of K. brevis  over a 21 day period; right: average EH activity 
of two strains of K. brevis over 21 day period (normalized to thousand cells) 
 
Expression of the EH mRNA was also monitored over the same period by Q-
PCR.  Figure 49 shows the ratio of cycle thresholds (Ct) for the EH mRNA normalized to 
RuBisCO mRNA. As higher Ct results from less mRNA, EH mRNA levels of the low 
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toxin culture were either lower (Ct higher) or equal to that of the high toxin culture when 
normalized to RuBisCO. On average over the life of the culture, EH mRNA amount in 
two strains has a significant difference, even though gene expression in dinoflagellates is 
believed to occur principally at the translational level 106. 
 
Figure 49. Left: Ratio of Ct for EH/RuBisCO for low and high toxin K. brevis; right: Average 
ratio of Ct for EH/RuBisCO 
 
3.3 CONCLUSIONS 
The EH identified from K. brevis EST library was cloned and expressed in E. coli. 
SDS-PAGE showed the EH was the anticipated size of 44 kD. The enzyme was 
confirmed to be an EH rather than esterase by comparing activity with two fluorescent 
probes 1 and 2. No activity was observed with the esterase probe 1.   
As natural substrates of K. brevis EH would be very challenging to synthesize, 
other simple substrates were used to obtain indirect evidence of EH involvement of 
brevetoxin biosynthesis. The selectivity of the expressed K. brevis EH for aliphatic 
epoxides coupled with the consistently higher level of EH activity in the high toxin vs 
low toxin cultures of K. brevis is intriguing and may implicate the involvement of the EH 
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in brevetoxin biosynthesis. However, the expressed EH did not appear to be capable of 
catalyzing the cyclization of epoxy alcohol 7 to either a furan or pyran. However, epoxy 
alcohol 7 may not sufficiently resemble the native substrate.  Lsd19 was also not capable 
of catalyzing the cyclization of monoepoxy alcohol which was significantly smaller than 
pre-lasalocid. 
The K. brevis EH showed a preference for terminal epoxides over  non-terminal 
epoxides. Inhibition studies using fluorescent probes as substrate, and other epoxides as 
competitive inhibitors revealed preference for cis- over trans- substituted internal 
epoxides. Even with terminal epoxides, the kcat was lower than those observed for soluble 
EHs. All these are consistent with microsomal EH characters.  
The K. brevis EH showed only slight enantioselectivity on R over S enatiomer 
with a ratio of 1.08 for R/S styrene oxide and 1.15 for R/S 1-butane oxide. It has further 
been suggested that an epoxidase could catalyze both the epoxidation and cyclization for 
PE ladder formation without the need for EH involvement. Therefore, further studies on 
epoxidase in K. brevis would possible reveal what is responsible for the enatioselectivity 
in ladder polyether compound biosynthesis. 
 
3.4 MATERIAL AND METHODS 
3.4.1 Material 
Gene expression vector pET-30a+ and expression E. coli strain BL21/de3 were 
kindly provided by Dr. Leng (FIU). Restriction Enzymes NdeI and HindIII were 
purchased from New England Biolabs (Beverly, MA). High fidelity DNA polymerase 
Pfx50 kit and TOPO TA cloning kit were purchased from Invitrogen (Grand Island, NY). 
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Primers were designed using the Primer-BLAST on NCBI and synthesized by Invitrogen 
(Grand Island, NY). QIAprep Spin Miniprep Kit, Qiaquick gel extraction kit and Ni-NTA 
agarose were purchased from Qiagen (Germantown, MD). Bacterial Protein Extraction 
reagent (B-PER) was purchased from Thermo Scientific. Unstained Protein Ladders were 
purchased from Bio-Rad. PCR reactions were performed on a Eppendorf Mastercycler 
Gradient thermal cycler. Optical density (OD600) was measured with a micro-plate reader 
(Synergy™ 2 from Bioteck Instruments, Inc.) Protein expression induction reagent 
isopropyl-β-D-thiogalactoside (IPTG) was purchased from Sigma-Aldrich. LB agar and 
LB broth were purchased from Becton Dickinson (Franklin Lakes, NJ). The substrates of 
EH, such as styrene oxide, 1-butane oxide or their corresponding precursor alkene, such 
as trans-methylstyrene, cis-methylstyrene were purchased from Sigma-Aldrich. iQ SYBR 
Green Supermix was purchased from Bio-Rad (Hercules, CA). Q-PCR reactions were 
performed using a DNA Engine from MJ Research (now Bio-Rad).  
 
3.4.2 Methods 
Amplification of EH gene 
Pfx50 DNA polymerase, which offers 50 times better fidelity than Taq DNA 
polymerase, was used to amplify the target gene. The PCR reaction components were 
mixed according to the pfx50 DNA polymerase manufacurer’s instructions. The 
concentration of each component in PCR are as following: dNTP (200 µM), reaction 
buffer (1x), primers (0.05-1 µM for both forward and reverse), template DNA ( <1,000 
ng) taq DNA polymerase (1.25 unit/50 µL PCR). The reactions were carried out by using 
the following steps: initial denaturation at 94 ºC for 2 minutes followed by 35 cycles of 
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94 ºC for 15 seconds (denaturation), 65 ºC for 30 seconds (annealing), and 68 ºC for 30 
seconds (extension).  
 
Ligation of PCR products and TA vector 
The PCR products were treated with 2 units of Taq DNA polymerase for 30 
minutes to add an “A” at both 5 and 3’ ends. The PCR products were then purified by 
running an agarose gel and the band of the anticipated size was extracted from the gel 
using Qiagen Gel Extration kit. The ligation was performed using Invitrogen TOPO TA 
cloning kit by following the manufacture’s instructions. The recombinant plasmid was 
transformed into Invitrogen’s Mach1™ competent E. coli cells provided with the cloning 
kit. After incubating and shaking in SOC medium at 37 ºC (250 rpm for 1 hour), 50 μL 
transformed E. coli cells were spread on LB agar with ampicillin (50 µg/mL) and X-gal 
(40 µg/mL) and incubated at 37 ºC overnight. White colonies were picked and grown in 
LB broth (5 mL) with ampicillin (50 µg/mL). Plasmids were extracted using QIAprep 
Spin Miniprep Kit (Qiagen) according to the manufacturer’s instructions.  
 
Recombination of EH gene with pET-30a+ 
The pCR TOPO plasmid containing the EH gene insert and expression vector 
pET-30a+ were digested by NdeI and HindIII at 37 ºC for 4 hours. The EH gene (1.2 kb) 
with cohesive ends was separated through agarose gel electrophoresis and extracted using 
the Gel Extration kit (Qiagen). Doubly enzyme-digested EH gene was ligated to the NdeI 
and HindIII restriction sites of the expression vector pET-30a+ using T4 DNA ligase 
(Invitrogen) according to the manufacturer’s instructions. 
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The newly constructed plasmid was transformed into the expression strain 
BL21(DE3) by electroporation. Transformed cells were spread on LB agar plates 
supplemented with kanamycin (50 µg/mL). These were then cultivated at 37 ºC 
overnight. Twenty colonies were picked randomly and grown in LB broth with 
kanamycin (50 µg/mL). Plasmids were extracted using QIAprep Spin Miniprep Kit 
(Qiagen) according to the manufactuer’s instructions. Clones of the E. coli BL21(DE3) 
containing recombinant plasmid (6.6 kb) were selected by comparing the size of plasmids 
through agarose gel electrophoresis. The recombinant plasmids were sent to Eurofins 
Genomics for sequencing using T7 primer and T7 terminator primer, to insure the fidelity 
of the insert sequence. Glycerol stock were prepared by adding 15% sterilized glycerol 
and stored at -80 ºC until use. 
 
Protein Expression and purification 
The E. coli BL21/DE3 with recombinant pet30a+-KbEH was inoculated into LB 
broth with kanamycin (50 µg/mL) and shaken at 37 ºC (250 rpm) overnight. The 
overnight culture (5 mL) was diluted into fresh LB broth (500 mL) with kanamycin (50 
µg/mL), shaken at 37 ºC (250 rpm for 2 ~3 hour). IPTG (1mM final concentration) was 
added when the OD600 reached to 0.6 ~0.8.  After shaking another 4~6 hour, the culture 
was centrifuged (5000 x g for 10 min). Lysozyme (2 μL, 50 mg/mL) and DNAse I (2 μl, 
2500 unit/mL) as well as Bacterial Protein Extraction reagent (B-PER, Thermo Scientific, 
4mL/ gram of cells) were added to resuspend the pellets. After incubation at room 
temperature for 10 min, the lysate was centrifuged (15000 x g for 5 min) to separate 
insoluble proteins. The supernatant was loaded on to a column of 1 mL Ni-NTA agarose 
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(Qiagen), which was pretreated with 10 mL phosphate buffer (20 mM phosphate, 0.5 M 
NaCl, 5 mM imidazole, 10% glycerol, pH 7.9). The column was washed by washing 
buffer (20 mM phosphate, 0.5 M NaCl, 20 mM imidazole, 10% glycerol, pH 7.9) until no 
more protein was eluted (as determined by A280) in the wash (typically 10 mL). This was 
followed by elution buffer (20 mM phosphate, 0.5 M NaCl, 250 mM imidazole, 10% 
glycerol, pH 7.9) until no more protein was eluted also as determined by A280. The 
purified EH was dialyzed (MW cutoff 12-14 kD) in phosphate buffer (50 mM sodium 
phosphate, pH 7.0) at 0° to 4°C, overnight, flash frozen in liquid nitrogen and stored at -
80 ºC until use. 
 
SDS-PAGE 
Protein samples were mixed at 4:1 volume ratio with 5x loading buffer (10% w/v 
SDS, 10 mM β-mercapto-ethanol, 20% v/v glycerol, 0.2 M Tris-HCl, pH6.8, 0.05% w/v 
bromophenol blue), boiled for 5 min. The mixed protein samples and loading buffer (10 
μl) were separated by SDS-PAGE with stacking gel (1.25 mL 0.5 M Tris-HCl, pH 6.8, 
0.025 mL 20% (w/v) SDS, 0.67 mL acrylamide/bis-acrylamide (30%/0.8% w/v), 0.025 
mL 10% (w/v) ammonium persulfate (APS), 0.005 mL TEMED, 3.075 mL H2O) and 
separating gel (7.5 mL 1.5 M Tris-HCl, pH 8.8, 0.15 mL 20% (w/v) SDS, 15 mL 
acrylamide/bis-acrylamide (30%/0.8% w/v), 0.15 mL 10% (w/v) ammonium persulfate 
(APS), 0.02 mL TEMED, 7.2 mL H2O). 
 
Probe synthesis  
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The fluorescent probe 2 was prepared as previously described 90. A second probe 
2b was prepared in a procedure identical to that of 2 except that (E)-4-phenylbut-3-enoic 
acid was replaced with (E)-pent-2-enoic acid. Both alkene and epoxide were purified by 
radial chromatography on a chromatotron (Harrison Research Corp.) using plates coated 
with silica gel 60 PF254 containing gypsum, using 5:1 hexane/ethyl acetate.  
Spectroscopic data for probe 2 were consistent with literature data 90. 1H-NMR and 13C-
NMR data were acquired on a Bruker Avance spectrophotometer (400 MHz for proton). 
1H NMR spectra were referenced internally to the residual proton resonance in CDCl3 (δ 
= 7.26 ppm), or with tetramethylsilane (TMS, δ = 0.00 ppm) as the internal standard. 
Chemical shifts are reported as parts per million (ppm) in the δ scale downfield from 
TMS. 13C NMR spectra were recorded with continuous proton decoupling. Chemical 
shifts are reported in ppm from TMS with the solvent as the internal reference (CDCl3, δ 
= 77.0 ppm). Accurate mass spectra were acquired using a Bruker Daltonics – ultrOTOF-
Q, +ESI-Q-q-TOF. 
 
Alkene probe 1b (65%, colorless oil): 1H-NMR (CDCl3, 400 MHz): δ 7.94 (s, 1H), 7.80 
(t, 2H, J = 8.4 Hz), 7.53 (m, 1H), 7.15-7.23 (m, 2H), 6.57 (s, 1H), 5.47-5.66 (m, 2H), 
3.94 (s, 3H), 3.13 (m, 2H), 2.05 (m, 2H), 0.98 (t, 3H, J = 7.6Hz). 13C-NMR (CDCl3, 100 
MHz): δ 170.5, 159.1, 137.8, 135.5, 130.0, 128.4, 128.3, 128.0, 126.8, 125.1, 123.8, 
120.1, 119.1, 116.42, 105.9. HRMS (+ESI): calculated for C19H19NO3 [M+Na]+ 
332.1257, found 332.1250.  
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Epoxide probe 2b (11%, yield yellow oil): 1H-NMR (CDCl3, 400 MHz): δ 8.26 (s, 1H), 
7.80 (t, 2H, J = 8.8Hz), 7.52 (m, 1H), 7.15-7.26 (m, 2H), 6.60 (s, 1H), 3.94 (s, 3H), 3.08 
(m, 1H), 2.75 (m, 1H), 2.66 (m, 2H), 1.59 (m, 2H), 0.97 (t, 3H, J = 5.6 Hz). 13C-NMR 
(CDCl3, 100 MHz): δ 168.8, 159.0, 135.4, 129.9, 128.2, 128.0, 127.8, 126.3, 125.0, 
120.0, 116.0, 105.8, 63.4, 59.5, 55.4, 52.9, 37.3, 24.7, 9.6. HRMS (+ESI): calculated for 
C19H19NO4 [M+Na]+ 348.1167, found 348.1206.  
 
Synthesis of trans-4,5-epoxy-hexanol 7, 2-methyltetrahydro-2H-pyran-3-ol (8) and 1-
(tetrahydrofuran-2-yl)ethanol (9) were performed as previously described 105.  Trans-4-
hexen-1-ol (500 μL, 5.88 mmol) was mixed with NaHCO3 (1.775 g), acetone (5.6 mL) 
and ethyl acetate (20 ml). Oxone (2.6 g, 17.1 mmol) was dissolved in water (18 mL) and 
added dropwise to the trans-4-hexen-1-ol solution over a period of 40 min. The reaction 
was stirred for another hour. The organic solvents were evaporated in vacuo. The residue 
was extracted with ethyl acetate (20 mL). The organic layer was washed twice with an 
equal volume of brine, dried over anhydrous Na2SO4, filtered and the solvent evaporated 
in vacuo to yield trans-4,5-epoxy-hexanol 7 which was used in the next step without 
further purification. Spectroscopic data for 7 were consistent with literature data. Trans-
4,5-epoxy-hexanol 7 was treated with a solution boron trifluoride etherate in diethyl ether 
as described previously to produce a mixture of  8 and 9. Analysis by GC-MS showed 
two products with the same m/z (116) in a ratio of 1:5 which were assigned as 8 and 9 
respectively, based on previous reports 105.  
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Synthesis of cis-β-methylstyrene oxide, trans-β-methylstyrene oxide, β-dimethylstyrene 
oxide and α-methylstyrene oxide were performed using the corresponding alkene 
precursors. The alkene (500 μL) was mixed with NaHCO3 (1.775 g), acetone (5.6 mL) 
and diethyl ether (20 mL). Oxone (2.6 g, 17.1 mmol) was dissolved in water (18 mL) and 
added dropwise to the trans-4-hexen-1-ol solution over a period of 40 min. The reaction 
was stirred for another 3 hours to overnight. The organic solvents were evaporated in 
vacuum at 30 oC. The residue was extracted with ethyl ether (20 mL). The organic layer 
was washed twice with an equal volume of brine, dried over anhydrous Na2SO4, filtered 
and the solvent evaporated in vacuo to yield the epoxide. As some of the synthesized 
epoxides are low boiling, of extended exposure to vacuum often resulted lower yields. 
The structures of the epoxide products were confirmed by 1H-NMR (CDCl3, 400 MHz), 
which were consistent with literature data.  
 
EH/esterase assay (fluorescent) 
Fluorescent probe 1/1b, 2/2b (2 μL, 10 mM, final concentration100 μM) was 
added to K. brevis homogenate (198 μL) or purified EH (198 μL) in duplicate. 
Fluorescence was monitored at 330 nm EX/ 465 nm EM (Synergy™ 2, Bioteck 
Instrument, Inc.) every 5 minutes at 30°C. The concentration of reporter 3 was calculated 
from a calibration curve prepared by measuring the fluorescence of 7-methoxy-2-
naphthaldehyde (0, 3.1, 12, 25, 50 μM  in phosphate buffer (50 mM phosphate, pH 7.0). 
Fluorescence readings were normalized to protein concentration or cell number.  
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EH assay (GC-MS) 
Substrate (4 mM to 10 mM final concentrations), internal standard, 1-naphthol 
(concentrations ranging from 0.4 to 4 mM; the concentration was optimized for each 
substrate to a relative response ratio of 1:5 ~5:1 for substrate/internal standard in the GC-
MS), and purified EH (~0.1 mg) was combined in phosphate buffer (50 mM phosphate, 
pH 7.0). Aliquots were removed every 5 minute and extracted using an equal volume of 
dichloromethane. Samples were evaporated to dryness and reconstituted in 
dichloromethane to ~20 ppm. Samples were analyzed by GC-MS (Hewlett Packard 6890 
with Alltech 30 m, DB5, capillary column, 0.25 mm (ID) 0.25 μm initial temperature 80 
°C for 1 minute/increase to 300 °C at 10 °C/ minute/hold for 7 minutes) and compared to 
standard curve of either the diol product or starting epoxide with the internal standard. 
Each reaction was performed in duplicate.  
 
EH assay (cyclization reaction) 
Trans-4,5-epoxy-hexanol 9  ( 1 μL 0.4 M stock solution in DMSO diluted to a 
final concentration of 4 mM) was incubated with protein (100 μL 0.1 mg/mL in dialysis 
buffer) or dialysis buffer (100 μL) alone at 30°C for 1 to 3 h. The reaction was extracted 
using an equal volume of dichloromethane. The organic extracts were evaporated to 
dryness and reconstituted in dichloromethane to ~20 ppm and analyzed by GC-MS as 
previously described.  
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Determination of KM and kcat 
Specific enzyme activity was determined by the fluorescence assay (5a and 5b) or 
by GC-MS for non-fluorescent products. A constant enzyme concentration of the EH 
(100 μL, 0.1mg/mL, ~1.926 μM) was incubated with a range of substrate concentrations. 
For fluorescent probes (2, 2b), the final concentrations of substrate were 0, 25, 50, 75 and 
100 μM. For other substrates, the final concentrations of substrate were 4, 6, 8, and 10 
mM. The assays were performed as previous described. Lineweaver-Burk plots were 
obtained using initial velocities of substrate and their corresponding concentration, and 
Km, Vmax and Vmax/Km were determined from the generated equation. These 
experiments were performed in duplicate.  
 
Inhibition assays 
          IC50 values could be obtained by either using fixed substrate concentration with 
different concentration of inhibitors or several different substrate concentrations with a 
fixed inhibitor concentration. IC50 were determined using fluorescent substrate 2b 
(100uM). EH (0.1 mg/mL) was incubated with inhibitors for 2 min in phosphate buffer 
(50mM, pH 7.0) at 30 °C prior to addition of the substrate. EH activity was measure as 
previously described by monitoring the fluorescence. Assays were performed by 
duplicate. By definition, IC50 value is concentration of inhibitor that reduces EH activity 
by 50%. Six concentrations of inhibitors (0, 2, 4, 8, 12, 16 mM) were assayed to obtain 
an inhibition curve of inhibition/inhibitor concentration.  
 
 
81 
 
RNA isolation 
K. brevis culture (100 mL) was centrifuged (450 x g for 5 min) at 20° C. The 
pellet was resuspended in water (100 µL). Denaturing solution (600 µL, 5 M guanidium 
thiocyanate, 50 mM Tris pH 8, 25 mM sodium citrate, 0.5% w/v Sarkosyl, 2% PEG, 0.1 
M DTT) was added. After standing at room temperature for 10 minutes, NaOAc (60 µL, 
3 M, pH 5.2) was added and the mixture was vortexed. An equal volume of phenol: 
chloroform: isoamyl alcohol (125:24:1, pH 4.3), was added and the mixture centrifuged 
at (14,000 x g for 15 minutes) at 4°C. The top (aqueous) phase was transferred to a new 
tube followed by the addition of equal volume chloroform: isoamyl alcohol (24:1) and 
the mixture was vortexed. After centrifugation at (14,000 x g for 15 minutes) at 4°C, the 
top (aqueous) phase was transferred to new tube which contains equal volume of ice cold 
EtOH. RNA was allowed to precipitate at -20 degrees overnight. The mixture was 
centrifuged at 4° C, for (30 minutes at 14,000 x g) and the pellet was washed with cold 
70% EtOH (700 µl). After air-drying, the pellet was reconstituted in water (50 µL).  Total 
RNA concentration was quantitated using the Nanodrop 2000 (Thermo Scientific).  
 
RT-PCR 
Using the isolated RNA (~1µg) as template and oligo dT as primer (1 μL, 50 
mM), cDNA was synthesized using the AMV First Strand cDNA Synthesis kit (Life 
Technologies) according to the manufacturer’s instructions. Reverse transcriptase 
reactions were diluted 1:5 in water. PCR reactions were carried out using the newly 
synthesized cDNA (1 μL of the diluted reverse transcriptase reaction), PCR mix (25 μL, 
iQ SYBR Green Supermix, Bio-Rad), 1 μL of each primer (50 mM). EH primer set: 
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forward; CAAGGTGCTGGGTCCTTTGG. Reverse; TTCCGGAGCGTTGAAACCAC. 
RuBisCO primers set: forward; GCAGCCTTTTATGCGGTATCG. Reverse; 
CACCAGCCATTCGCATCCATTT. PCR reactions were monitored using the DNA 
Engine Opticon (MJ Research) which can detect Sybr green (excitation: 497 nm, 
emission: 520 nm) fluorescence. Cycling conditions: 94 °C denaturation for 1 min, 
annealing for 45 sec at 60°C, extension 72°C (RuBisCO primer set only, no extension 
time for EH primers), repeat 40 cycles. The efficiency of the PCR mix was determined by 
titrating the template cDNA concentrations by dilution of the RT reactions (1:5, 1:25 and 
1:125) in water. Efficiencies were calculated to be ~90 to 95%.   
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4. FUTURE DIRECTION 
In the previous chapter, one EH identified from a K. brevis EST library was 
cloned and expressed. Through the enzymatic reactions with different substrates, and by 
EH activity monitoring over life time of the culture oftwo K. brevis strains, some 
evidence was obtained to support the proposed biosynthetic pathway of ladder polyether 
compounds. However, no direct evidence revealed the involvement of an EH in the 
biosynthesis of brevetoxins due to lack of natural-similar substrates. For the same reason, 
the potential of EH in semi-enzymatic synthesis to carry out kinetically disfavored 
cyclization was not developed. In this chapter, some thoughts about further study of the 
role of EH in biosynthesis of ladder polyethers will be discussed.  
 
4.1 SYNTHESIZE OF MORE APPROPRIATE ENZYME SUBSTRATES 
The study of Lsd19, the EH responsible for lasalocid cyclizations, revealed that 
the substrates’ similarity to natural substrates significantly effected enzyme efficiency 107. 
As mentioned in chapter 3, Lsd19 did show any activity towards the most simple 
monoepoxy alcohol. The cyclization ability of monensin EHs was also evaluated using 
several substrates. The substrates with different length of aliphatic chains (Figure 50) 
were tested. Under the same conditions, the conversion of epoxide to cyclization products 
was 0%, 12%, 13%, and 30% when using C2, C6, C7 and C10 analogs 88. Apparently, the 
C10 analog was most similar to the proposed natural substrates of monensin EH. 
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Figure 50. Substrates analog studied in monensin EHs 
 
Therefore, in order to achieve successful cyclization reactions for K. brevis EH, it 
is essential to obtain a natural substrate analog. As the complicity of brevetoxins, even 
the smaller product brevenal, it is of great challenge to synthesize natural substrates of K. 
brevis EH. Fortunately, the structure elucidation of brevisamide 108, suggested the K. 
brevis EH may also act on some less complex substrates. 
 
 
Figure 51. Structure of brevismide 
 
Nerolidol is a potential precursor for synthesizing K. brevis EH substrates. Both 
cis and trans nerolidol could be purchased from Sigma-Aldrich. Figure 52 shows a 
scheme to synthesize the substrates of EH. The product of moneepoxide (Figure 52, left) 
is analog of brevisamide, whereas the product of bisepoxide (Figure 52, right) contains 
the first two rings of brevenal.   
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Figure 52. Scheme for syntheizing K. brevis EH substrates using nerolidol 
 
4.2 CHARACTERIZE THE OTHER α,β-FOLD EH  
Three K. brevis reference transcriptome libraries containing 86,580 (Wilson 
strain), 93,668 (strain SP1) and 84,309 (strain SP3) predicted transcripts 100 became 
available. As discussed in chapter, another α, β-fold EH was identified from these three 
libraries. Further sequence analysis revealed that it was also microsomal EH. As previous 
reported, many organism had more than one EHs that were involved in the biosynthesis 
of polyethers, such as MonBI, MonBII in monensin biosynthesis and Lsd19A, Lsd19B in 
lasalocid biosynthesis. Suppose the hypothesis of biosynthesis of brevetoxins is true, it is 
not known that how many EHs are involved in it. Therefore, it is worthy to characterize 
the other EH found in K. brevis EST library.  
 
4.3 CONTINUE TO SEARCH FOR LIMONENE EH 
 By comparing of mechanisms of α, β-fold EH and LEH, the one-step direct 
hydrolysis performed by LEH is more likely involved in polyether cascade cyclization 89a. 
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In fact, as to now, all EHs confirmed to be involved in the biosynthesis of polyethers are 
LEHs.  
In previous chapter, different methods were discussed to search for LEH. 
However,no sequences similar to LEH were identified. After another three K. brevis EST 
libraries were published 89a, using the known LEHs, MonB1, MonB2, Lsd19A, Lsd19B, 
NanIA,  NanIB, TmnB, NigB1 and NigB3, which were identified from polyether 
biosynthetic gene clusters as query, searches were made on the new libraries. However, 
still no LEH was found.   
 The fact that all the query sequences were from bacteria may be the reason for the 
failure to find LEH in the eukaryote K. brevis. However, no LEHs in eukaryotes were 
reported to be involved in the biosynthesis of polyether. BLASTp analysis of those 
known LEHs revealed that these enzymes belong to NTF2-like (Nuclear transport factor) 
superfamily, which includes members of the NTF2 family, Δ-5-3-ketosteroid isomerases, 
scytalone dehydratases, and the beta subunit of ring hydroxylating dioxygenases. In the 
sequences, a SnoaL domain, which belongs to the family of small polyketide cyclases 
was detected. SnoaL was recognized as polyketide cyclase and was found in the 
biosynthesis of nogalamycin 109 and was responsible for the cyclization of last ring 
(Figure 53).   
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Figure 53. Biosynthesis of nagalamycin 
 
The BLASTp results drive us using other polyketide cyclase from other 
organisms rather than bacteria as query to search for LEH. One hundred and seventy-
three polyketide cyclase from green plant were available in NCBI protein database. Of 
those one hundred and seventy-three, eight were from green algae. Using all polyketide 
cyclase sequences from green algae and another five sequences randomly chosen from 
green plants as query, searches on all available K. brevis EST libraries were made. 
Nothing was found from Marine Genomics K. brevis EST library, however, all three 
transcriptome libraries contained one sequence with an E-value at 1.0e-5 with the 
polyketide cyclase (Accession: CEG01925.1) from Ostreococcus tauri. BLASTp analysis 
of this sequence against NCBI protein database revealed an NTF2-like domain, as other 
known LEH, and a HAD-like (haloacid dehalogenase) domain.  
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